1. Introduction {#sec1}
===============

Oxidative stress is a major physiological phenomenon, mediated through the production of reactive oxygen species (ROS), such as peroxides, superoxide, hydroxyl radical, and singlet oxygen. ROS play an important role in cell homeostasis and pathogen response and are therefore essential in biological processes. In contrast, increases in ROS are seen in various age-related diseases including glaucoma \[[@B1]\]. For instance, in the aqueous humor of glaucoma patients, the levels of oxidative stress markers are significantly increased \[[@B2]--[@B5]\]. Additionally, oxidative DNA damage is reportedly increased in the trabecular meshwork (TM) of glaucoma patients \[[@B6], [@B7]\]. These findings indicate that the TM of glaucomatous eyes is continuously exposed to oxidative stress, and therefore, damage to TM may increase outflow resistance and the risk of glaucoma progression. In line with this, lower systemic antioxidant capacity is related to higher intraocular pressure (IOP) levels in open-angle glaucoma patients \[[@B8]\]. Moreover, glaucoma-related genes, such as *CYP1B1* and *FOXC1*, are reportedly linked to oxidative stress in the eyes \[[@B9]--[@B12]\]. Taken together, control of oxidative stress in the eye may be a therapeutic target to slow glaucoma progression.

Rho-rho kinase (ROCK) signaling controls polymerization of actin and thereby mediates various cell functions, such as contraction, migration, phagocytosis, and mitosis. Inhibition of ROCK increases aqueous outflow by depolymerizing F-actin in TM cells and Schlemm\'s canal endothelial cells \[[@B13], [@B14]\]. A ROCK inhibitor, ripasudil, has been approved as an IOP-lowering drug in Japan \[[@B15]\]. Ripasudil significantly reduces the IOP of glaucoma patients upon either single or multiple administration \[[@B16], [@B17]\]. However, ROCK inhibitors have drawn attention as antioxidative drugs against cardiovascular diseases and chronic renal injury \[[@B18], [@B19]\]. Indeed, ripasudil (also known as K-115) has been reported to have a neuroprotective effect on the optic nerve by suppressing oxidative stress in an animal model \[[@B20]\]. Thus, the effect of ROCK inhibitors on oxidative stress in TM cells is of interest from a therapeutic point of view against glaucoma.

Here, we show the results of an exhaustive investigation using a microarray, revealing that treatment with Y-27632, a well-known ROCK inhibitor, upregulates antioxidative molecules in TM cells, inhibits ROS production, and promotes cell survival.

2. Materials and Methods {#sec2}
========================

2.1. Cell Culture {#sec2.1}
-----------------

Trabecular meshwork (TM) cells were isolated from the eyes of cynomolgus monkeys (Shin Nippon Biomedical Laboratories, Kagoshima, Japan) according to the method described previously \[[@B21]\]. Primary TM cells were cultured in Dulbecco\'s modified Eagle\'s medium (DMEM; Wako, Osaka, Japan) supplemented with 10% FBS, 2 mM glutamine, 100 U/mL penicillin, 100 *μ*g/mL streptomycin, and 0.5 *μ*g/mL amphotericin B at 37°C in 5% CO~2~. These cells were used after 2--5 passages. The character of the isolated cells in the present study was confirmed by expression of specific TM markers (caveolin 1, collagen 4*α*5, matrix gla protein, tissue inhibitor of metalloproteinase 3, and vascular cell adhesion protein 1), phagocytosis function, and myocilin induction by dexamethasone as described previously \[[@B22]\].

2.2. DNA Microarray Analysis {#sec2.2}
----------------------------

Custom cDNA microarray analysis was performed using a CombiMatrix microarray (CombiMatrix, Mukilteo, WA) as described previously \[[@B23]\]. Briefly, the cynomolgus monkey array was designed to detect directly labeled mRNA from 12,613 probes. Confluent TM cells in 100 mm dishes were treated with 25 *μ*M Y-27632 (Merck Millipore, Darmstadt, Germany) or vehicle (deionized water) for 30 min. Total RNA was extracted from the cells, and the integrity and concentration of total RNA was measured using an Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA). Fluorescence-labeled antisense RNA was synthesized by direct incorporation of Cy5-UTP or Cy3-UTP, using each RNA sample and an RNA Transcript SureLABEL Core kit (Takara Bio, Shiga, Japan). Labeled antisense RNAs were hybridized simultaneously with the microarray chips. DNA microarray preparation, hybridization, processing, scanning, and analyses were performed according to the manufacturer\'s instructions (Filgen, Nagoya, Japan). Fluorescent images of hybridized microarrays were obtained with a GenePix 4000B Scanner (Molecular Devices, Sunnyvale, CA). Array-Pro Analyzer Ver4.5 (Media Cybernetics, Silver Spring, MD) was used to determine the signal intensity of each spot and its local background. Scanned images were analyzed using Microarray Data Analysis Tool Ver3.2 software (Filgen). Signals from Y-27632 treated cells were compared with those from vehicle-treated cells, and genes that showed greater than 3/2-fold change in expression in at least one of the pairwise probe comparisons were considered upregulated, whereas those that showed a change of expression smaller than 2/3-fold were considered downregulated. These analyses were performed three times using TM cells from three different monkeys independently, and genes with common differences in expression among the three experiments were identified as affected genes. The affected genes were further analyzed by gene ontology, in which putative functions of gene products were categorized as "biological process," "cellular component," or "molecular function" by a BLAST homology search of EST sequences available from the National Center for Biotechnology Information.

2.3. Real-Time RT-PCR {#sec2.3}
---------------------

Total RNA was isolated from cultured TM cells treated with Y-27632 for 30 min using NucleoSpin RNA (Macherey-Nagel, Düren, Germany). Total RNA was reverse transcribed (PrimeScript RT Master Mix; Takara Bio Inc., Shiga, Japan) according to the manufacturer\'s protocol. Quantitative real-time RT-PCR was performed using an ABI Prism 7000 (Life Technologies). Reactions were performed in 20 *μ*L of reaction mixture containing 10 *μ*L PCR master mix (SYBR Premix Ex Taq II; Takara Bio Inc.), 0.4 *μ*M primer pairs, and 2 *μ*L cDNA samples. The gene-specific primer pairs were as follows: monkey catalase, forward (F) 5′-GCA AAT CTG TGA GGC CGG GG-3′; reverse (R) 5′-GCG CAT CTA GCA CCG GAG AA-3′ and 18S ribosomal RNA, (F) 5′-GCC CGA AGC GTT TAC TTT GA-3′; (R) 5′-CCG CGG TCC TAT TCC ATT ATT-3′. The thermal cycling conditions were 95°C for 30 s and 40 cycles of 95°C for 5 s and 60°C for 31 s. All PCR reactions were performed in duplicate.

Relative expression of catalase in the Y-27632-treated samples was compared to that in control samples using the comparative C~T~ method (ΔΔC~T~ method); 18S ribosomal RNA was used as an endogenous control. The threshold cycle, C~T~, was determined after setting the threshold in the linear amplification phase of the PCR reaction and ΔC~T~ was defined as ΔC~T~ = C~T~ (target gene) − C~T~ (18S rRNA). Relative expression of the target gene was calculated as: 2^−ΔΔCT^, ΔΔC~T~ = ΔC~T~ (treated sample) − ΔC~T~ (control).

2.4. Intracellular Oxidative Stress Detection {#sec2.4}
---------------------------------------------

The effects of Y-27632 on the production of ROS were evaluated using CellROX® green reagent (Life Technologies) in the TM cells. These cells were cultured on 6 cm dishes in DMEM containing 10% FBS and antibiotics at 37°C in 5% CO~2~. After cells had grown to confluence, they were pretreated with Y-27632 for 30 min and then stimulated with 100 *μ*M menadione (Sigma, St. Louis, MO) for 1 h. CellROX reagent was then added to each dish to give a final concentration of 5 *μ*M and incubated for 30 min at 37°C. After incubation, TM cells were washed in PBS and detached by trypsin/EDTA solution and centrifuged at 1200 rpm for 3 min. The supernatant was removed, and cells were fixed in 4% paraformaldehyde in PBS for 15 min and then centrifuged twice at 1200 rpm for 3 min, resuspending in PBS after each spin. FITC fluorescence of TM cells was analyzed using a Cell Sorter SH800 (Sony Biotechnology, Tokyo, Japan).

2.5. Cell Viability Assay {#sec2.5}
-------------------------

The effects of Y-27632 on TM cell viability were evaluated using the WST-8 assay (Cell Counting Kit-8, Dojindo Laboratories, Kumamoto, Japan). Cells were seeded on 96-well plates (1 × 10^4^ cells/well) and incubated at 37°C under 5% CO~2~ overnight. After pretreatment with Y-27632 for 30 min, cells were stimulated with H~2~O~2~ or menadione for 24 h. CCK-8 reagents were added into each well and incubated for 2 h at 37°C. Absorbance at 450 nm was determined using a microplate reader (Multiskan FC, Thermo Fisher Scientific). Cell viability was expressed as a percentage of control (vehicle-treated) cells.

2.6. Direct Antioxidant Activity of Y-27632 {#sec2.6}
-------------------------------------------

Direct antioxidant activity was assessed by 2-methyl-6-p-methoxyphenylethynylimidazopyrazinone (AB-2950 MPEC; ATTO, Tokyo, Japan), a superoxide-sensitive luminescent reagent, and reagents for xanthine-oxidase-induced superoxide production (AB-2970 CLETA-S, ATTO) following the manufacturer\'s protocol. Briefly, 10 *μ*L of 300 *μ*M MPEC/ethanol and 80 *μ*L of 1.25 unit/mL xanthine oxidase/HEPES were mixed. Then, 10 *μ*L of 25 *μ*M Y-27632 or 20 mM n-acetyl cysteine (positive control) was added into each well of a 96-well plate. Subsequently, 90 *μ*L of the mixture of MPEC and xanthine oxidase and 200 *μ*L of xanthine were added to each well. The luminescent signal was measured for 10 s by a luminometer (AB-2270 Octa; ATTO).

2.7. Statistical Analysis {#sec2.7}
-------------------------

Data are presented as means ± standard error. Statistical comparisons of multiple groups were performed using the Tukey-Kramer HSD test and Dunnett\'s test, and those of two groups were performed using Wilcoxon rank sum test and Wilcoxon signed rank test. Differences were considered statistically significant at *P* \< 0.05.

3. Results {#sec3}
==========

3.1. Microarray Expression Profile in Y-27632-Treated TM Cells {#sec3.1}
--------------------------------------------------------------

Among the 12,613 genes analyzed by microarray, the affected genes are listed in Tables [1](#tab1){ref-type="table"} and [2](#tab2){ref-type="table"}; 444 genes were upregulated, and 56 were downregulated. Significantly upregulated and downregulated gene categories based on gene ontology analysis in Y-27632 treated TM cells are listed in Tables [3](#tab3){ref-type="table"} and [4](#tab4){ref-type="table"}. Gene ontology analysis revealed that the upregulated genes were related to various cellular functions including antioxidant activity (*P* = 0.014), and downregulated genes were related to integrin complexes (*P* = 0.039), and calcium ion transport into the cytosol (*P* = 0.008). In the category of antioxidant activity, upregulated genes were homologous to human gene coding catalase (*P* = 0.046), thioredoxin domain-containing 2 (also known as spermatozoa; *P* = 0.032), nucleoredoxin (*P* = 0.017), albumin (probe 1, *P* = 0.002; probe 2, *P* = 0.021), and glutathione transferase zeta 1 (*P* = 0.004). Upregulation of the mRNA of catalase, an extensively investigated antioxidant, was confirmed by real-time RT-PCR and found to be 1.5 times higher in TM cells treated with Y-27632 compared to the control TM cells (*P* = 0.032; [Figure 1(a)](#fig1){ref-type="fig"}). In contrast, four other genes involved in antioxidant activity were not significantly affected after treatment with Y-27632 (data not shown).

3.2. Effects of Y-27632 on the Production of Reactive Oxygen Species in TM Cells {#sec3.2}
--------------------------------------------------------------------------------

To assess the effects of Y-27632 on the production of ROS in TM cells, we utilized a fluorogenic probe that exhibits bright fluorescence upon oxidation by ROS. In the absence of an oxidative reagent, the fluorescence intensity was not significantly different in TM cells treated with Y-27632 compared to control (3673.2 ± 452.3 versus 5104.5 ± 735.0; [Figure 1(b)](#fig1){ref-type="fig"}). In the presence of 100 *μ*M menadione, the fluorescence intensity was significantly elevated (16097.7 ± 1133.0; *P* \< 0.0001); this elevation was partly suppressed by treatment with Y-27632 (11443.6 ± 1332.2; *P* = 0.0182), suggesting that Y-27632 reduces ROS production in TM cells under oxidative stress.

3.3. Effects of Y-27632 on the Viability of TM Cells under Oxidative Stress {#sec3.3}
---------------------------------------------------------------------------

Finally, we investigated the effects of Y-27632 on the viability of TM cells under oxidative stress. As shown in [Figure 2(a)](#fig2){ref-type="fig"}, menadione reduced TM cell viability in a dose-dependent manner. At a lower dose of menadione, Y-27632-stimulated TM cells regained significant viability against menadione treatment compared to control cells (*P* = 0.0238). In contrast, the effects of Y-27632 on cell viability were not significant at a higher dose of menadione.

3.4. Direct Antioxidant Activity of Y-27632 {#sec3.4}
-------------------------------------------

To confirm the extracellular antioxidant activity of Y-27632, we assessed xanthine oxidase-induced superoxide production using a luminescent reagent. As shown in [Figure 2(b)](#fig2){ref-type="fig"}, there was no significant difference in ROS production between the control and Y-27632 treatment. Thus, Y-27632 does not appear to affect extracellular oxidants.

4. Discussion {#sec4}
=============

In the present study, we have identified the antioxidative effect of Y-27632 in TM cells by microarray analysis, an exhaustive investigation of gene expression, and shown that Y-27632 partially suppresses ROS production and cell death induced by menadione. To the best of our knowledge, this is the first report to show the antioxidant effect of ROCK inhibitor on TM cells. Previously, we presented depolymerization of F-actin before morphometric recovery from oxidative stress in TM cells \[[@B24]\], suggesting a correlation between oxidative stress and regulation of the actin cytoskeleton in TM cells. In other tissues, rho-kinase was identified as a mediator of various diseases associated with inflammation and oxidative stress, and inhibition of rho-kinase has been drawing attention as a promising therapeutic strategy. For instance, activation of the rho/rho-kinase pathway is related to the pathophysiology of chronic renal injury, and long-term fasudil treatment has renoprotective effects in this malignant hypertension model. The mechanism of the renoprotective effect of fasudil, a nonspecific ROCK inhibitor, was suggested to involve a combination of factors, including inhibition of the TGF-*β*-collagen cascade, control of inflammation, reduction of oxidative stress, and upregulation of eNOS \[[@B18]\]. Clinical studies with fasudil have suggested that it may be useful for the treatment of a wide range of cardiovascular diseases \[[@B19]\]. Importantly, rho-kinase inhibitors block ROS production by suppressing CyPA secretion from vascular smooth muscle cells \[[@B25]\], suggesting the beneficial effect of rho-kinase inhibitors against cardiovascular diseases.

Recently, Yamamoto and colleagues demonstrated the neuroprotective effect of the ROCK inhibitor K-115, a novel IOP-lowering drug, using the mouse optic crush model \[[@B20]\]. They showed the effect was at least partially dependent on suppression of ROS production via inhibition of *Nox1* expression in retinal ganglion cells. We also showed that ROCK inhibitors\' antioxidant effects are indirect using monkey TM cells. However, in the present study using microarray analysis, *Nox* family genes were not identified as affected, but catalase was upregulated after treatment with Y-27632. This disagreement might be caused by differences in species and/or tissues. Thus, the precise molecular mechanisms of the antioxidative effect of ROCK inhibitors have not been clarified completely. On the other hand, a recent study reported that Y-27632 induced p-53-mediated apoptosis in hemangioma \[[@B26]\]. In the present study, we indicated that ROCK inhibitor effected cell survival in TM cells. This is interesting point since ROCK inhibitor-induced effects such as cell death or cell protection were changed by differences of cell types.

TM has a critical role in the maintenance of aqueous outflow resistance through the regulation of extracellular matrix metabolism, phagocytosis of debris, and empty space associated with tissue contraction \[[@B27], [@B28]\]. Indeed, the number of TM cells is decreased in glaucomatous eyes \[[@B29]\], suggesting that functional TM cells are essential in controlling IOP. In this context, oxidative stress is a potential cause of cellular dysregulation in TM, both functionally and numerally, because it has been suggested that the TM of glaucomatous eyes is continuously exposed to oxidative stress \[[@B2]--[@B7]\]. Thus, an antioxidant drug might reduce oxidative stress in TM cells, slowing progression of glaucomatous damage in outflow tissues. Though it remains unknown whether clinically used eye-drops containing ripasudil have significant antioxidative effects on TM cells in vivo, the present study\'s findings may be clinically relevant.

The effect of Y-27632 on cell survival under oxidative stress was significant, but limited. Since glaucoma progresses chronically in the majority of the patients, the acute oxidative damage in the present study may not reflect pathological conditions in glaucomatous TM cells, which is one of the limitations of the present study. Another limitation is that the antioxidative effects of ROCK inhibition were not corroborated in vivo. Further studies are required to acquire more clinically relevant evidence of the effects of ROCK inhibitor on oxidative stress in TM.

5. Conclusion {#sec5}
=============

Microarray analysis reveals that Y-27632 upregulates antioxidative genes including catalase and partially reduces the ROS production and cell death by oxidative stress induced by menadione.
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![(a) Quantitative PCR analysis of catalase mRNA. The TM cells were treated with 25 *μ*M Y-27632 for 30 min. The relative expression level of *catalase* of samples treated with Y-27632 was compared to that of the control sample using the comparative C~T~ method (ΔΔC~T~ method). The 18S ribosomal RNA was used as an endogenous control. Data are shown as mean ± SE from six independent experiments. ^∗^*P* \< 0.05 compared with control by Wilcoxon rank sum test. (b) The effects of Y-27632 on the intracellular production of reactive oxygen species (ROS). The TM cells were treated with or without 25 *μ*M Y-27632 for 30 min, followed by 100 *μ*M menadione stimulated for 1 h. ROS were detected by CellROX reagent, and the fluorescence of the TM cells were measured by cell sorter SH800. Data are shown as mean ± SE from five independent experiments. ^∗∗^*P* \< 0.01 and ^∗^*P* \< 0.05 compared with control by the Wilcoxon rank sum test (a) and Tukey Kramer HSD test (b).](JOPH2017-7598140.001){#fig1}

![(a) The effect of Y-27632 on oxidative stress-induced cell death. The TM cells were treated with or without 25 *μ*M Y-27632 for 30 min, followed by menadione stimulation of the cells for 24 h. Cell viabilities were shown as relative value compared with the control. Data are shown as the mean ± SE from six independent experiments. ^∗^*P* \< 0.05 compared with control by Wilcoxon rank sum test. (b) The effect of Y-27632 on extracellular antioxidative activity. The xanthine-oxidase-induced superoxide production was assessed using a superoxide-sensitive luminescent reagent. Data are shown as the mean ± SE from six independent experiments. ^∗^*P* \< 0.05 compared with the control by Dunnett\'s test. Nac: n-acetyl cysteine.](JOPH2017-7598140.002){#fig2}

###### 

Genes that are upregulated in TM cells.

  Accession number   Human RefSeq description                                                                                                                                                            Fold change
  ------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------
  DW528016           gi\|75750485\|ref\|NM_004773.2 *Homo sapiens* zinc finger, HIT type 3 (ZNHIT3), mRNA                                                                                                6.79928
  CJ434702           gi\|20986504\|ref\|NM_002753.2 *Homo sapiens* mitogen-activated protein kinase 10 (MAPK10), transcript variant 1, mRNA                                                              5.85538
  AB168851           gi\|224586874\|ref\|NM_033124.4 *Homo sapiens* coiled-coil domain-containing 65 (CCDC65), mRNA                                                                                      5.77453
  AB169150           gi\|223555972\|ref\|NR_026827.1 *Homo sapiens* hypothetical LOC84856 (LOC84856), noncoding RNA                                                                                      5.01086
  DW523643           gi\|225903398\|ref\|NM_001146152.1 *Homo sapiens* cytochrome P450, family 51, subfamily A, polypeptide 1 (CYP51A1), transcript variant 2, mRNA                                      4.6977
  AK240630           gi\|4503754\|ref\|NM_002021.1 *Homo sapiens* flavin-containing monooxygenase 1 (FMO1), mRNA                                                                                         4.64946
  BB894083           gi\|154689768\|ref\|NM_020840.1 *Homo sapiens* folliculin-interacting protein 2 (FNIP2), mRNA                                                                                       4.52052
  AB168218           gi\|85060516\|ref\|NM_199321.2 *Homo sapiens* zona pellucida-binding protein 2 (ZPBP2), transcript variant 2, mRNA                                                                  4.20286
  AB168199           gi\|156523965\|ref\|NM_001102470.1 *Homo sapiens* alcohol dehydrogenase 6 (class V) (ADH6), transcript variant 1, mRNA                                                              3.89514
  AB172502           gi\|50897849\|ref\|NM_001001936.1 *Homo sapiens* actin filament-associated protein 1-like 2 (AFAP1L2), transcript variant 1, mRNA                                                   3.84241
  CJ448047           gi\|46909588\|ref\|NM_002731.2 *Homo sapiens* protein kinase, cAMP-dependent, catalytic, beta (PRKACB), transcript variant 2, mRNA                                                  3.75324
  DC857227           gi\|239752603\|ref\|XM_002348257.1 PREDICTED: *Homo sapiens* similar to immunoglobulin lambda-like polypeptide 1 (LOC100294459), mRNA                                               3.66898
  CJ449582           gi\|9506614\|ref\|NM_019023.1 *Homo sapiens* protein arginine methyltransferase 7 (PRMT7), mRNA                                                                                     3.64058
  EF208813           gi\|24797075\|ref\|NM_002121.4 *Homo sapiens* major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA                                                                3.57386
  DQ417745           gi\|194,248,050\|ref\|NM_000839.3 *Homo sapiens* glutamate receptor, metabotropic 2 (GRM2), transcript variant 1, mRNA                                                              3.5509
  AB049894           gi\|66571326\|ref\|NM_020914.3 *Homo sapiens* ring finger protein 213 (RNF213), mRNA                                                                                                3.51068
  DC850932           gi\|117676364\|ref\|NM_014350.2 *Homo sapiens* tumor necrosis factor, alpha-induced protein 8 (TNFAIP8), transcript variant 1, mRNA                                                 3.47535
  BB877436           gi\|142360165\|ref\|NM_005123.2 *Homo sapiens* nuclear receptor subfamily 1, group H, member 4 (NR1H4), mRNA                                                                        3.46906
  AB174726           gi\|22208962\|ref\|NM_016150.3 *Homo sapiens* ankyrin repeat and SOCS box-containing 2 (ASB2), mRNA                                                                                 3.30479
  AB174122           gi\|209862773\|ref\|NM_002483.4 *Homo sapiens* carcinoembryonic antigen-related cell adhesion molecule 6 (nonspecific cross-reacting antigen) (CEACAM6), mRNA                       3.27904
  AB173773           gi\|38569483\|ref\|NM_017641.2 *Homo sapiens* kinesin family member 21A (KIF21A), mRNA                                                                                              3.26679
  DK578446           gi\|15718677\|ref\|NM_033257.2 *Homo sapiens* DiGeorge syndrome critical region gene 6 like (DGCR6L), mRNA                                                                          3.26114
  AB168950           gi\|38261961\|ref\|NM_018179.3 *Homo sapiens* activating transcription factor 7-interacting protein (ATF7IP), mRNA                                                                  3.25607
  CJ488707           gi\|45333915\|ref\|NM_178456.2 *Homo sapiens* chromosome 20 open reading frame 85 (C20orf85), mRNA                                                                                  3.24156
  DC639327           gi\|154800442\|ref\|NM_005074.3 *Homo sapiens* solute carrier family 17 (sodium phosphate), member 1 (SLC17A1), mRNA                                                                3.23693
  BB895966           gi\|32483409\|ref\|NM_000583.2 *Homo sapiens* group-specific component (vitamin D-binding protein) (GC), mRNA                                                                       3.22662
  DQ417744           gi\|194248050\|ref\|NM_000839.3 *Homo sapiens* glutamate receptor, metabotropic 2 (GRM2), transcript variant 1, mRNA                                                                3.1862
  AB168486           gi\|195972893\|ref\|NM_152764.2 *Homo sapiens* chromosome 16 open reading frame 73 (C16orf73), mRNA                                                                                 3.17552
  AB047624           gi\|45446748\|ref\|NM_004984.2 *Homo sapiens* kinesin family member 5A (KIF5A), mRNA                                                                                                3.1749
  CJ446015           gi\|187761371\|ref\|NM_004044.5 *Homo sapiens* 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase (ATIC), mRNA                                      3.17026
  AB171508           gi\|89276768\|ref\|NM_002747.3 *Homo sapiens* mitogen-activated protein kinase 4 (MAPK4), mRNA                                                                                      3.12296
  DC639656           gi\|148596946\|ref\|NM_001098483.1 *Homo sapiens* chromosome 10 open reading frame 125 (C10orf125), transcript variant 1, mRNA                                                      3.11887
  AB048996           gi\|211938419\|ref\|NM_002898.3 *Homo sapiens* RNA-binding motif, single stranded interacting protein 2 (RBMS2), mRNA                                                               3.11444
  DC630823           gi\|215422360\|ref\|NM_004786.2 *Homo sapiens* thioredoxin-like 1 (TXNL1), transcript variant 1, mRNA                                                                               3.09601
  AB173283           gi\|197927150\|ref\|NM_006158.3 *Homo sapiens* neurofilament, light polypeptide (NEFL), mRNA                                                                                        3.09117
  DC633065           gi\|34486089\|ref\|NM_004152.2 *Homo sapiens* ornithine decarboxylase antizyme 1 (OAZ1), mRNA                                                                                       3.0599
  AB174730           gi\|115387109\|ref\|NM_017831.3 *Homo sapiens* ring finger protein 125 (RNF125), mRNA                                                                                               3.03611
  AB046044           gi\|170650673\|ref\|NM_000440.2 *Homo sapiens* phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A), mRNA                                                                        3.03568
  AB179171           gi\|82546851\|ref\|NM_175605.3 *Homo sapiens* intraflagellar transport 88 homolog (*Chlamydomonas*) (IFT88), transcript variant 1, mRNA                                             3.029
  AB051155           gi\|35493712\|ref\|NM_017890.3 *Homo sapiens* vacuolar protein sorting 13 homolog B (yeast) (VPS13B), transcript variant 5, mRNA                                                    3.00764
  AB072740           gi\|155029549\|ref\|NM_178828.4 *Homo sapiens* chromosome 9 open reading frame 79 (C9orf79), mRNA                                                                                   3.00753
  BB881371           gi\|162809333\|ref\|NM_002864.2 *Homo sapiens* pregnancy-zone protein (PZP), mRNA                                                                                                   2.99069
  CJ463711           gi\|215272411\|ref\|NM_001142334.1 *Homo sapiens* ataxin 2-binding protein 1 (A2BP1), transcript variant 6, mRNA                                                                    2.98758
  AB170648           gi\|5174424\|ref\|NM_006052.1 *Homo sapiens* Down syndrome critical region gene 3 (DSCR3), mRNA                                                                                     2.9606
  AB220465           gi\|58331245\|ref\|NM_000817.2 *Homo sapiens* glutamate decarboxylase 1 (brain, 67 kDa) (GAD1), transcript variant GAD67, mRNA                                                      2.95173
  AB062990           gi\|33149330\|ref\|NM_022463.3 *Homo sapiens* nucleoredoxin (NXN), mRNA                                                                                                             2.94787
  AB220509           gi\|139394620\|ref\|NM_006574.3 *Homo sapiens* chondroitin sulfate proteoglycan 5 (neuroglycan C) (CSPG5), mRNA                                                                     2.92569
  AB070086           gi\|22538813\|ref\|NM_002985.2 *Homo sapiens* chemokine (C-C motif) ligand 5 (CCL5), mRNA                                                                                           2.92446
  AB173147           gi\|194294550\|ref\|NM_015989.4 *Homo sapiens* cysteine sulfinic acid decarboxylase (CSAD), mRNA                                                                                    2.91509
  AB051133           gi\|28329444\|ref\|NM_014379.2 *Homo sapiens* potassium channel, subfamily V, member 1 (KCNV1), mRNA                                                                                2.87085
  AB174705           gi\|51477720\|ref\|NM_001003811.1 *Homo sapiens* testis-expressed 11 (TEX11), transcript variant 1, mRNA                                                                            2.86731
  CJ469703           gi\|169646771\|ref\|NM_002064.2 *Homo sapiens* glutaredoxin (thioltransferase) (GLRX), transcript variant 1, mRNA                                                                   2.85957
  AB220438           gi\|109633045\|ref\|NM_001042437.1 *Homo sapiens* ST3 beta-galactoside alpha-2,3-sialyltransferase 5 (ST3GAL5), transcript variant 2, mRNA                                          2.85364
  BB881475           gi\|170650673\|ref\|NM_000440.2 *Homo sapiens* phosphodiesterase 6A, cGMP-specific, rod, alpha (PDE6A), mRNA                                                                        2.84456
  AB168610           gi\|62632749\|ref\|NM_014616.1 *Homo sapiens* ATPase, class VI, type 11B (ATP11B), mRNA                                                                                             2.84449
  AB173806           gi\|134031964\|ref\|NR_003491.1 *Homo sapiens* myocardial infarction associated transcript (nonprotein coding) (MIAT), noncoding RNA                                                2.82677
  AB063045           gi\|190570175\|ref\|NM_152906.4 *Homo sapiens* chromosome 22 open reading frame 25 (C22orf25), mRNA                                                                                 2.80672
  AB168446           gi\|223278411\|ref\|NR_026782.1 *Homo sapiens* chromosome 1 open reading frame 175 (C1orf175), transcript variant 2, transcribed RNA                                                2.79215
  CJ473171           gi\|215490055\|ref\|NM_001142434.1 *Homo sapiens* meningioma-expressed antigen 5 (hyaluronidase) (MGEA5), transcript variant 2, mRNA                                                2.78342
  CJ450383           gi\|83641894\|ref\|NM_031157.2 *Homo sapiens* heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), transcript variant 2, mRNA                                                      2.78321
  DW528650           gi\|58430810\|ref\|NM_148912.2 *Homo sapiens* abhydrolase domain-containing 11 (ABHD11), transcript variant 1, mRNA                                                                 2.77238
  AB362499           gi\|48255911\|ref\|NM_012338.3 *Homo sapiens* tetraspanin 12 (TSPAN12), mRNA                                                                                                        2.76878
  AB173195           gi\|196049386\|ref\|NM_002198.2 *Homo sapiens* interferon regulatory factor 1 (IRF1), mRNA                                                                                          2.76544
  AB168743           gi\|188536107\|ref\|NM_001127458.1 *Homo sapiens* cardiolipin synthase 1 (CRLS1), transcript variant 2, mRNA                                                                        2.76042
  CJ444006           gi\|157151724\|ref\|NM_001004333.3 *Homo sapiens* ribonuclease, RNase K (RNASEK), mRNA                                                                                              2.75719
  DK583186           gi\|156631002\|ref\|NM_006913.3 *Homo sapiens* ring finger protein 5 (RNF5), mRNA                                                                                                   2.75394
  AB168582           gi\|239757151\|ref\|XM_002345145.1 PREDICTED: *Homo sapiens* hypothetical protein LOC100292623 (LOC100292623), mRNA                                                                 2.75285
  BB884235           gi\|70906436\|ref\|NM_000509.4 *Homo sapiens* fibrinogen gamma chain (FGG), transcript variant gamma-A, mRNA                                                                        2.74831
  AB070088           gi\|148613875\|ref\|NM_144715.3 *Homo sapiens* EF-hand domain family, member B (EFHB), mRNA                                                                                         2.74738
  AB174502           gi\|239757416\|ref\|XM_002345385.1 PREDICTED: *Homo sapiens* similar to hCG2019710 (LOC100294049), mRNA                                                                             2.73964
  AB172306           gi\|196162714\|ref\|NM_024786.2 *Homo sapiens* zinc finger, DHHC-type-containing 11 (ZDHHC11), mRNA                                                                                 2.72049
  BB878691           gi\|19743563\|ref\|NM_000766.3 *Homo sapiens* cytochrome P450, family 2, subfamily A, polypeptide 13 (CYP2A13), mRNA                                                                2.72031
  AB174483           gi\|55775474\|ref\|NM_194326.2 *Homo sapiens* ribosomal protein S19-binding protein 1 (RPS19BP1), mRNA                                                                              2.68579
  DC632651           gi\|22538474\|ref\|NM_018955.2 *Homo sapiens* ubiquitin B (UBB), mRNA                                                                                                               2.66418
  AB168353           gi\|197927266\|ref\|NM_004388.2 *Homo sapiens* chitobiase, di-N-acetyl (CTBS), mRNA                                                                                                 2.64444
  AB169323           gi\|156616291\|ref\|NM_018100.3 *Homo sapiens* EF-hand domain (C-terminal)-containing 1 (EFHC1), mRNA                                                                               2.6433
  AB048961           gi\|209413742\|ref\|NM_005458.6 *Homo sapiens* gamma-aminobutyric acid (GABA) B receptor, 2 (GABBR2), mRNA                                                                          2.63945
  AB173162           gi\|73747880\|ref\|NM_015113.3 *Homo sapiens* zinc finger, ZZ-type with EF-hand domain 1 (ZZEF1), mRNA                                                                              2.63631
  AB179192           gi\|237681201\|ref\|NM_019644.3 *Homo sapiens* ankyrin repeat domain 7 (ANKRD7), mRNA                                                                                               2.62211
  CJ469417           gi\|169790802\|ref\|NM_005271.2 *Homo sapiens* glutamate dehydrogenase 1 (GLUD1), mRNA                                                                                              2.62134
  AB172772           gi\|61835190\|ref\|NM_006578.3 *Homo sapiens* guanine nucleotide-binding protein (G protein), beta 5 (GNB5), transcript variant 1, mRNA                                             2.61592
  DC857715           gi\|169234652\|ref\|NM_007360.2 *Homo sapiens* killer cell lectin-like receptor subfamily K, member 1 (KLRK1), mRNA                                                                 2.6139
  AB179131           gi\|40807356\|ref\|NM_005094.2 *Homo sapiens* solute carrier family 27 (fatty acid transporter), member 4 (SLC27A4), mRNA                                                           2.61058
  DC647811           gi\|92091576\|ref\|NM_015533.3 *Homo sapiens* dihydroxyacetone kinase 2 homolog (*S. cerevisiae*) (DAK), mRNA                                                                       2.60217
  AB171456           gi\|197927256\|ref\|NM_001134664.1 *Homo sapiens* sterile alpha motif domain-containing 13 (SAMD13), transcript variant 3, mRNA                                                     2.59522
  CJ490832           gi\|169205007\|ref\|XM_001714899.1 PREDICTED: *Homo sapiens* hypothetical LOC100131988 (LOC100131988), mRNA                                                                         2.58063
  DC635714           gi\|57013275\|ref\|NM_006082.2 *Homo sapiens* tubulin, alpha 1b (TUBA1B), mRNA                                                                                                      2.57848
  AB055358           gi\|225735571\|ref\|NR_027416.1 *Homo sapiens* nuclear factor erythroid-derived 2-like 3 pseudogene (LOC100272146), noncoding RNA                                                   2.57079
  CJ458955           gi\|197382308\|ref\|NM_183394.2 *Homo sapiens* Ca^++^-dependent secretion activator (CADPS), transcript variant 2, mRNA                                                             2.55777
  DC636940           gi\|54112387\|ref\|NM_001005738.1 *Homo sapiens* formyl peptide receptor 2 (FPR2), transcript variant 2, mRNA                                                                       2.54881
  CJ493104           gi\|56676323\|ref\|NM_001001552.3 *Homo sapiens* LEM domain-containing 1 (LEMD1), mRNA                                                                                              2.5487
  AB172122           gi\|239754513\|ref\|XM_001716238.2 PREDICTED: *Homo sapiens* hypothetical LOC100128081 (LOC100128081), mRNA                                                                         2.54837
  CJ469678           gi\|197304748\|ref\|NM_032727.3 *Homo sapiens* internexin neuronal intermediate filament protein, alpha (INA), mRNA                                                                 2.53491
  AB070172           gi\|32490571\|ref\|NM_012307.2 *Homo sapiens* erythrocyte membrane protein band 4.1-like 3 (EPB41L3), mRNA                                                                          2.52667
  DW528013           gi\|225735571\|ref\|NR_027416.1 *Homo sapiens* nuclear factor erythroid-derived 2-like 3 pseudogene (LOC100272146), noncoding RNA                                                   2.52479
  AB171587           gi\|161169016\|ref\|NM_001111019.1 *Homo sapiens* neuron navigator 2 (NAV2), transcript variant 4, mRNA                                                                             2.5209
  BB888693           gi\|49574509\|ref\|NM_016013.2 *Homo sapiens* NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1 (NDUFAF1), mRNA                                                 2.51576
  BB897871           gi\|207113180\|ref\|NM_001097577.2 *Homo sapiens* angiogenin, ribonuclease, RNase A family, 5 (ANG), transcript variant 2, mRNA                                                     2.50309
  AB168153           gi\|222352148\|ref\|NM_018665.2 *Homo sapiens* DEAD (Asp-Glu-Ala-Asp) box polypeptide 43 (DDX43), mRNA                                                                              2.50236
  AB173823           gi\|148225856\|ref\|NM_001097579.1 *Homo sapiens* G protein-coupled receptor 34 (GPR34), transcript variant 4, mRNA                                                                 2.49912
  AB168907           gi\|194688136\|ref\|NM_002358.3 *Homo sapiens* MAD2 mitotic arrest deficient-like 1 (yeast) (MAD2L1), mRNA                                                                          2.49825
  DK583616           gi\|18390348\|ref\|NM_000972.2 *Homo sapiens* ribosomal protein L7a (RPL7A), mRNA                                                                                                   2.49444
  CJ471599           gi\|197245445\|ref\|NM_024958.2 *Homo sapiens* neurensin 2 (NRSN2), mRNA                                                                                                            2.49281
  AB179111           gi\|118572587\|ref\|NM_001761.2 *Homo sapiens* cyclin F (CCNF), mRNA                                                                                                                2.49071
  AB060886           gi\|23199979\|ref\|NM_022470.2 *Homo sapiens* zinc finger, matrin type 3 (ZMAT3), transcript variant 1, mRNA                                                                        2.48362
  AB056810           gi\|126131101\|ref\|NM_138694.3 *Homo sapiens* polycystic kidney and hepatic disease 1 (autosomal recessive) (PKHD1), transcript variant 1, mRNA                                    2.48299
  DC645529           gi\|4501988\|ref\|NM_001134.1 *Homo sapiens* alpha-fetoprotein (AFP), mRNA                                                                                                          2.46808
  AB050420           gi\|189095267\|ref\|NM_000554.4 *Homo sapiens* cone-rod homeobox (CRX), mRNA                                                                                                        2.45627
  AB243403           gi\|116235483\|ref\|NM_002701.4 *Homo sapiens* POU class 5 homeobox 1 (POU5F1), transcript variant 1, mRNA                                                                          2.4534
  AB173020           gi\|94420687\|ref\|NM_004233.3 *Homo sapiens* CD83 molecule (CD83), transcript variant 1, mRNA                                                                                      2.44967
  DC643036           gi\|50409862\|ref\|NM_017584.5 *Homo sapiens* myoinositol oxygenase (MIOX), mRNA                                                                                                    2.44791
  BB897024           gi\|142976728\|ref\|NM_016245.3 *Homo sapiens* hydroxysteroid (17-beta) dehydrogenase 11 (HSD17B11), mRNA                                                                           2.43894
  DW522619           gi\|34147617\|ref\|NM_138807.2 *Homo sapiens* chromosome 3 open reading frame 31 (C3orf31), mRNA                                                                                    2.43416
  DC645828           gi\|16332359\|ref\|NM_033487.1 *Homo sapiens* cell division cycle 2-like 1 (PITSLRE proteins) (CDC2L1), transcript variant 3, mRNA                                                  2.43092
  AB050260           gi\|203098333\|ref\|NM_032133.4 *Homo sapiens* MYCBP-associated protein (MYCBPAP), mRNA                                                                                             2.41286
  CJ436262           gi\|150010638\|ref\|NM_015276.1 *Homo sapiens* ubiquitin specific peptidase 22 (USP22), mRNA                                                                                        2.39886
  AB056381           gi\|225735571\|ref\|NR_027416.1 *Homo sapiens* nuclear factor erythroid-derived 2-like 3 pseudogene (LOC100272146), noncoding RNA                                                   2.39471
  CJ443349           gi\|83367079\|ref\|NM_003801.3 *Homo sapiens* glycosylphosphatidylinositol anchor attachment protein 1 homolog (yeast) (GPAA1), mRNA                                                2.39333
  AB171767           gi\|126273571\|ref\|NM_144586.5 *Homo sapiens* LY6/PLAUR domain-containing 1 (LYPD1), transcript variant 1, mRNA                                                                    2.393
  AB056817           gi\|58535452\|ref\|NM_001011649.1 *Homo sapiens* CDK5 regulatory subunit-associated protein 2 (CDK5RAP2), transcript variant 2, mRNA                                                2.39285
  AB174345           gi\|145208007\|ref\|NM_173688.2 *Homo sapiens* Na^+^/K^+^-transporting ATPase interacting 3 (NKAIN3), mRNA                                                                          2.39236
  DC648733           gi\|134133239\|ref\|NM_032151.4 *Homo sapiens* pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2 (PCBD2), mRNA           2.39231
  CJ435057           gi\|189083855\|ref\|NM_000815.4 *Homo sapiens* gamma-aminobutyric acid (GABA) A receptor, delta (GABRD), mRNA                                                                       2.38598
  AB172049           gi\|41281366\|ref\|NM_001440.2 *Homo sapiens* exostoses (multiple)-like 3 (EXTL3), mRNA                                                                                             2.37312
  CJ489397           gi\|71143136\|ref\|NM_005342.2 *Homo sapiens* high-mobility group box 3 (HMGB3), mRNA                                                                                               2.36471
  AB170096           gi\|42741653\|ref\|NM_007375.3 *Homo sapiens* TAR DNA-binding protein (TARDBP), mRNA                                                                                                2.36217
  AB056391           gi\|169216999\|ref\|XM_001720515.1 PREDICTED: *Homo sapiens* similar to pro-pol protein (LOC100129323), mRNA                                                                        2.3496
  AB071089           gi\|167900475\|ref\|NM_001080850.2 *Homo sapiens* coiled-coil domain-containing 30 (CCDC30), mRNA                                                                                   2.34558
  DK579603           gi\|84626579\|ref\|NM_025108.2 *Homo sapiens* chromosome 16 open reading frame 59 (C16orf59), mRNA                                                                                  2.34371
  CJ431113           gi\|226246632\|ref\|NR_027451.1 *Homo sapiens* hypothetical LOC647979 (LOC647979), noncoding RNA                                                                                    2.34265
  DK580610           gi\|34335291\|ref\|NM_003312.4 *Homo sapiens* thiosulfate sulfurtransferase (rhodanese) (TST), nuclear gene encoding mitochondrial protein, mRNA                                    2.3426
  AB168450           gi\|81295815\|ref\|NM_012337.2 *Homo sapiens* coiled-coil domain-containing 19 (CCDC19), mRNA                                                                                       2.34063
  DQ159931           gi\|163659857\|ref\|NM_000828.4 *Homo sapiens* glutamate receptor, ionotrophic, AMPA 3 (GRIA3), transcript variant 2, mRNA                                                          2.33939
  AB173516           gi\|36287116\|ref\|NM_014319.3 *Homo sapiens* LEM domain-containing 3 (LEMD3), mRNA                                                                                                 2.33925
  AB173575           gi\|56550100\|ref\|NM_020978.3 *Homo sapiens* amylase, alpha 2B (pancreatic) (AMY2B), mRNA                                                                                          2.33548
  AB169015           gi\|93277104\|ref\|NM_173812.4 *Homo sapiens* dpy-19-like 2 (*C. elegans*) (DPY19L2), mRNA                                                                                          2.33006
  BB898675           gi\|70906438\|ref\|NM_021870.2 *Homo sapiens* fibrinogen gamma chain (FGG), transcript variant gamma-B, mRNA                                                                        2.32385
  DK579646           gi\|153791317\|ref\|NM_032332.3 *Homo sapiens* mitogen-activated protein kinase organizer 1 (MORG1), transcript variant 2, mRNA                                                     2.32308
  AB071115           gi\|111548669\|ref\|NM_153376.2 *Homo sapiens* coiled-coil domain-containing 96 (CCDC96), mRNA                                                                                      2.31559
  DC632824           gi\|23110926\|ref\|NM_002799.2 *Homo sapiens* proteasome (prosome, macropain) subunit, beta type, 7 (PSMB7), mRNA                                                                   2.31501
  BB896362           gi\|188595719\|ref\|NM_005141.3 *Homo sapiens* fibrinogen beta chain (FGB), mRNA                                                                                                    2.3131
  AB292416           gi\|143770740\|ref\|NM_001083899.1 *Homo sapiens* glycoprotein VI (platelet) (GP6), transcript variant 1, mRNA                                                                      2.311
  AB055350           gi\|67782353\|ref\|NM_001024844.1 *Homo sapiens* CD82 molecule (CD82), transcript variant 2, mRNA                                                                                   2.31014
  AB168962           gi\|210147405\|ref\|NM_152621.5 *Homo sapiens* sphingomyelin synthase 2 (SGMS2), transcript variant 1, mRNA                                                                         2.30806
  AB168166           gi\|156415985\|ref\|NM_014579.2 *Homo sapiens* solute carrier family 39 (zinc transporter), member 2 (SLC39A2), mRNA                                                                2.30287
  AB172981           gi\|73695942\|ref\|NM_001010927.2 *Homo sapiens* T-cell lymphoma invasion and metastasis 2 (TIAM2), transcript variant 2, mRNA                                                      2.29903
  CJ441025           gi\|153252025\|ref\|NM_001830.3 *Homo sapiens* chloride channel 4 (CLCN4), mRNA                                                                                                     2.29786
  CJ445440           gi\|42764686\|ref\|NM_022652.2 *Homo sapiens* dual specificity phosphatase 6 (DUSP6), transcript variant 2, mRNA                                                                    2.29536
  AB179072           gi\|156119614\|ref\|NM_006901.2 *Homo sapiens* myosin IXA (MYO9A), mRNA                                                                                                             2.28584
  AB060229           gi\|239756940\|ref\|XM_001718053.2 PREDICTED: *Homo sapiens* similar to CD300C antigen (LOC100130520), mRNA                                                                         2.28415
  CJ480802           gi\|71772428\|ref\|NM_001021.3 *Homo sapiens* ribosomal protein S17 (RPS17), mRNA                                                                                                   2.28212
  DK581053           gi\|63054873\|ref\|NM_001615.3 *Homo sapiens* actin, gamma 2, smooth muscle, enteric (ACTG2), mRNA                                                                                  2.27782
  AB046030           gi\|169210010\|ref\|XR_040492.1 PREDICTED: *Homo sapiens* hypothetical LOC440386 (LOC440386), miscRNA                                                                               2.27371
  AB174638           gi\|44680147\|ref\|NM_203327.1 *Homo sapiens* solute carrier family 23 (nucleobase transporters), member 2 (SLC23A2), transcript variant 2, mRNA                                    2.2635
  CJ469779           gi\|95147340\|ref\|NM_004603.2 *Homo sapiens* syntaxin 1A (brain) (STX1A), mRNA                                                                                                     2.25959
  DC632108           gi\|225637497\|ref\|NR_003286.2 *Homo sapiens* 18S ribosomal RNA (LOC100008588), noncoding RNA                                                                                      2.25815
  AB170956           gi\|65506441\|ref\|NM_000282.2 *Homo sapiens* propionyl coenzyme A carboxylase, alpha polypeptide (PCCA), nuclear gene encoding mitochondrial protein, transcript variant 1, mRNA   2.25785
  DC858184           gi\|13569959\|ref\|NM_030980.1 *Homo sapiens* interferon stimulated exonuclease gene 20 kDa-like 2 (ISG20L2), mRNA                                                                  2.25755
  CJ470090           gi\|169790838\|ref\|NM_004172.4 *Homo sapiens* solute carrier family 1 (glial high affinity glutamate transporter), member 3 (SLC1A3), mRNA                                         2.24996
  DW522847           gi\|215983055\|ref\|NM_031471.5 *Homo sapiens* fermitin family homolog 3 (*Drosophila*) (FERMT3), transcript variant URP2SF, mRNA                                                   2.23483
  DK577957           gi\|186910295\|ref\|NM_001126102.1 *Homo sapiens* haptoglobin (HP), transcript variant 2, mRNA                                                                                      2.23107
  AB168531           gi\|162951880\|ref\|NM_001112707.1 *Homo sapiens* tousled-like kinase 2 (TLK2), transcript variant B, mRNA                                                                          2.22872
  AB047603           gi\|149363673\|ref\|NM_012194.1 *Homo sapiens* chromosome 11 open reading frame 41 (C11orf41), mRNA                                                                                 2.22681
  DC642489           gi\|66392201\|ref\|NM_002512.2 *Homo sapiens* nonmetastatic cells 2, protein (NM23B) expressed in (NME2), transcript variant 1, mRNA                                                2.22176
  AB072760           gi\|91754184\|ref\|NM_152763.3 *Homo sapiens* chromosome 1 open reading frame 62 (C1orf62), mRNA                                                                                    2.2183
  AB168708           gi\|36287109\|ref\|NM_194429.1 *Homo sapiens* FGFR1 oncogene partner (FGFR1OP), transcript variant 2, mRNA                                                                          2.21393
  AB168136           gi\|93004101\|ref\|NM_005730.3 *Homo sapiens* CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase 2 (CTDSP2), mRNA                                    2.20887
  DC641033           gi\|108389126\|ref\|NM_001042353.1 *Homo sapiens* family with sequence similarity 110, member A (FAM110A), transcript variant 3, mRNA                                               2.20687
  CJ453010           gi\|19743893\|ref\|NM_133480.1 *Homo sapiens* transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L), transcript variant 2, mRNA                                             2.20608
  AB168419           gi\|32996736\|ref\|NM_173083.2 *Homo sapiens* lin-9 homolog (C. elegans) (LIN9), mRNA                                                                                               2.20292
  AB169251           gi\|148727318\|ref\|NM_001098529.1 *Homo sapiens* thioredoxin domain-containing 2 (spermatozoa) (TXNDC2), transcript variant 2, mRNA                                                2.2019
  AB173492           gi\|31542657\|ref\|NM_018099.3 *Homo sapiens* fatty acyl CoA reductase 2 (FAR2), mRNA                                                                                               2.20171
  CJ443285           gi\|62955828\|ref\|NM_033428.1 *Homo sapiens* chromosome 9 open reading frame 123 (C9orf123), mRNA                                                                                  2.19894
  AB169808           gi\|20336295\|ref\|NM_018380.2 *Homo sapiens* DEAD (Asp-Glu-Ala-Asp) box polypeptide 28 (DDX28), nuclear gene encoding mitochondrial protein, mRNA                                  2.1907
  AB169213           gi\|125625349\|ref\|NM_001790.3 *Homo sapiens* cell division cycle 25 homolog C (S. pombe) (CDC25C), transcript variant 1, mRNA                                                     2.18403
  CJ491693           gi\|21361889\|ref\|NM_021633.2 *Homo sapiens* Kelch-like 12 (*Drosophila*) (KLHL12), mRNA                                                                                           2.1801
  BB876451           gi\|109389366\|ref\|NM_000312.2 *Homo sapiens* protein C (inactivator of coagulation factors Va and VIIIa) (PROC), mRNA                                                             2.17421
  AB171871           gi\|153070253\|ref\|NM_001099680.1 *Homo sapiens* MAGI family member, X-linked (MAGIX), transcript variant 2, mRNA                                                                  2.17287
  AB173097           gi\|198041927\|ref\|NM_139241.2 *Homo sapiens* FYVE, RhoGEF and PH domain-containing 4 (FGD4), mRNA                                                                                 2.16791
  AB046632           gi\|136255215\|ref\|NM_207351.3 *Homo sapiens* proline-rich transmembrane protein 3 (PRRT3), mRNA                                                                                   2.16598
  DK577943           gi\|84872083\|ref\|NR_002798.1 *Homo sapiens* napsin B aspartic peptidase pseudogene (NAPSB), noncoding RNA                                                                         2.16578
  AB168792           gi\|141802709\|ref\|NM_145263.2 *Homo sapiens* spermatogenesis associated 18 homolog (rat) (SPATA18), mRNA                                                                          2.16491
  BB881148           gi\|189458840\|ref\|NM_005942.3 *Homo sapiens* molybdenum cofactor synthesis 1 (MOCS1), transcript variant 2, mRNA                                                                  2.16393
  CJ472360           gi\|24497456\|ref\|NM_139136.2 *Homo sapiens* potassium voltage-gated channel, Shaw-related subfamily, member 2 (KCNC2), transcript variant 1, mRNA                                 2.15994
  CJ430900           gi\|94721262\|ref\|NM_001040446.1 *Homo sapiens* myotubularin-related protein 12 (MTMR12), mRNA                                                                                     2.15957
  AB171550           gi\|19913413\|ref\|NM_014203.2 *Homo sapiens* adaptor-related protein complex 2, alpha 1 subunit (AP2A1), transcript variant 1, mRNA                                                2.1589
  AB173954           gi\|188595678\|ref\|NM_014959.2 *Homo sapiens* caspase recruitment domain family, member 8 (CARD8), mRNA                                                                            2.13719
  AB071125           gi\|89903024\|ref\|NM_001031735.2 *Homo sapiens* chromosome 19 open reading frame 36 (C19orf36), transcript variant 1, mRNA                                                         2.13665
  AB063014           gi\|170650671\|ref\|NM_001122769.1 *Homo sapiens* Leber congenital amaurosis 5 (LCA5), transcript variant 2, mRNA                                                                   2.13524
  DC631520           gi\|189163527\|ref\|NM_001127700.1 *Homo sapiens* serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 (SERPINA1), transcript variant 4, mRNA        2.1306
  AY742821           gi\|59806358\|ref\|NM_006011.3 *Homo sapiens* ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 (ST8SIA2), mRNA                                                          2.12885
  AK240628           gi\|160298141\|ref\|NM_000668.4 *Homo sapiens* alcohol dehydrogenase 1B (class I), beta polypeptide (ADH1B), mRNA                                                                   2.12458
  AB174195           gi\|30794215\|ref\|NM_030961.1 *Homo sapiens* tripartite motif-containing 56 (TRIM56), mRNA                                                                                         2.12446
  DC646861           gi\|91807120\|ref\|NM_033087.3 *Homo sapiens* asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae) (ALG2), transcript variant 1, mRNA           2.12291
  AY650365           gi\|27436932\|ref\|NM_172337.1 *Homo sapiens* orthodenticle homeobox 2 (OTX2), transcript variant 2, mRNA                                                                           2.11514
  DW527197           gi\|219555668\|ref\|NM_052855.3 *Homo sapiens* ankyrin repeat domain 40 (ANKRD40), mRNA                                                                                             2.115
  AB171287           gi\|188497721\|ref\|NM_001127385.1 *Homo sapiens* cortexin 3 (CTXN3), transcript variant 2, mRNA                                                                                    2.11438
  AB173764           gi\|219879811\|ref\|NM_005475.2 *Homo sapiens* SH2B adaptor protein 3 (SH2B3), mRNA                                                                                                 2.10791
  DK582787           gi\|221316657\|ref\|NM_004811.2 *Homo sapiens* leupaxin (LPXN), transcript variant 2, mRNA                                                                                          2.10555
  AB070128           gi\|217416373\|ref\|NM_145038.2 *Homo sapiens* chromosome 2 open reading frame 39 (C2orf39), mRNA                                                                                   2.10225
  AB070165           gi\|226491198\|ref\|NM_182496.2 *Homo sapiens* coiled-coil domain-containing 38 (CCDC38), mRNA                                                                                      2.10075
  DK577398           gi\|52426772\|ref\|NM_002122.3 *Homo sapiens* major histocompatibility complex, class II, DQ alpha 1 (HLA-DQA1), mRNA                                                               2.09004
  AB169904           gi\|34147601\|ref\|NM_004309.3 *Homo sapiens* rho GDP dissociation inhibitor (GDI) alpha (ARHGDIA), mRNA                                                                            2.08484
  AB220503           gi\|237681178\|ref\|NM_001160260.1 *Homo sapiens* cannabinoid receptor 1 (brain) (CNR1), transcript variant 6, mRNA                                                                 2.08434
  AB173401           gi\|239750034\|ref\|XR_039406.2 PREDICTED: *Homo sapiens* similar to yippee-like 5 (*Drosophila*) (LOC100132562), miscRNA                                                           2.08407
  AB171785           gi\|253970447\|ref\|NM_014253.3 *Homo sapiens* odz, odd Oz/ten-m homolog 1(*Drosophila*) (ODZ1), transcript variant 3, mRNA                                                         2.08184
  AB171491           gi\|117938287\|ref\|NM_004171.3 *Homo sapiens* solute carrier family 1 (glial high affinity glutamate transporter), member 2 (SLC1A2), mRNA                                         2.08087
  AB174571           gi\|182765446\|ref\|NM_001031711.2 *Homo sapiens* endoplasmic reticulum-Golgi intermediate compartment (ERGIC) 1 (ERGIC1), mRNA                                                     2.07886
  AB063092           gi\|34577113\|ref\|NM_015576.1 *Homo sapiens* ELKS/RAB6-interacting/CAST family member 2 (ERC2), mRNA                                                                               2.07171
  AB056378           gi\|189163523\|ref\|NM_033064.4 *Homo sapiens* ataxia, cerebellar, Cayman type (ATCAY), mRNA                                                                                        2.06758
  AB055299           gi\|163644324\|ref\|NM_001112732.1 *Homo sapiens* MCF.2 cell line derived transforming sequence-like (MCF2L), transcript variant 1, mRNA                                            2.06139
  AB172748           gi\|119220563\|ref\|NM_004852.2 *Homo sapiens* one cut homeobox 2 (ONECUT2), mRNA                                                                                                   2.05909
  AB172478           gi\|239746981\|ref\|XR_078603.1 PREDICTED: *Homo sapiens* similar to putative p150 (LOC100288106), miscRNA                                                                          2.05792
  AB170807           gi\|236459850\|ref\|NM_173569.3 *Homo sapiens* ubinuclein 2 (UBN2), mRNA                                                                                                            2.05471
  EF208824           gi\|239740919\|ref\|XM_002344047.1 PREDICTED: *Homo sapiens* similar to major histocompatibility complex, class II, DQ beta 1, transcript variant 2 (LOC100294318), mRNA            2.05031
  AB169481           gi\|150417992\|ref\|NM_033312.2 *Homo sapiens* CDC14 cell division cycle 14 homolog A (S. cerevisiae) (CDC14A), transcript variant 2, mRNA                                          2.04992
  AB171520           gi\|56243494\|ref\|NM_004586.2 *Homo sapiens* ribosomal protein S6 kinase, 90 kDa, polypeptide 3 (RPS6KA3), mRNA                                                                    2.0465
  DC629151           gi\|215982788\|ref\|NM_000477.5 *Homo sapiens* albumin (ALB), mRNA                                                                                                                  2.04345
  DC640591           gi\|208609965\|ref\|NM_001135664.1 *Homo sapiens* RAB7, member RAS oncogene family-like 1 (RAB7L1), transcript variant 4, mRNA                                                      2.04167
  BB887273           gi\|215,982,788\|ref\|NM_000477.5 *Homo sapiens* albumin (ALB), mRNA                                                                                                                2.0414
  CJ435276           gi\|75,812,975\|ref\|NM_001033574.1 *Homo sapiens* archaelysin family metallopeptidase 2 (AMZ2), transcript variant 6, mRNA                                                         2.04064
  DC643114           gi\|33519462\|ref\|NM_004544.2 *Homo sapiens* NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42 kDa (NDUFA10), nuclear gene encoding mitochondrial protein, mRNA           2.03575
  CJ436048           gi\|62865867\|ref\|NM_004102.3 *Homo sapiens* fatty acid-binding protein 3, muscle and heart (mammary-derived growth inhibitor) (FABP3), mRNA                                       2.03528
  AB179303           gi\|196162694\|ref\|NM_003401.3 *Homo sapiens* X-ray repair complementing defective repair in Chinese hamster cells 4 (XRCC4), transcript variant 1, mRNA                           2.03322
  AB171313           gi\|146219840\|ref\|NM_020709.1 *Homo sapiens* PNMA-like 2 (PNMAL2), mRNA                                                                                                           2.02925
  AB173369           gi\|149363694\|ref\|NM_001009984.1 *Homo sapiens* chromosome 20 open reading frame 194 (C20orf194), mRNA                                                                            2.01079
  AB171481           gi\|18496982\|ref\|NM_015526.1 *Homo sapiens* CAP-GLY domain-containing linker protein 3 (CLIP3), mRNA                                                                              2.00151
  AB174068           gi\|84872123\|ref\|NR_002833.1 *Homo sapiens* dpy-19-like 2 pseudogene 1 (*C. elegans*) (DPY19L2P1), noncoding RNA                                                                  1.99958
  AB050434           gi\|239753181\|ref\|XM_002345525.1 PREDICTED: *Homo sapiens* similar to hCG2041348 (LOC100293610), mRNA                                                                             1.99905
  DK577438           gi\|88999575\|ref\|NM_002622.4 *Homo sapiens* prefoldin subunit 1 (PFDN1), mRNA                                                                                                     1.99519
  AB172315           gi\|239753426\|ref\|XR_038411.2 PREDICTED: *Homo sapiens* similar to eukaryotic translation elongation factor 1 beta 2 (LOC646973), miscRNA                                         1.99372
  BB895222           gi\|38372939\|ref\|NM_001185.2 *Homo sapiens* alpha-2-glycoprotein 1, zinc-binding (AZGP1), mRNA                                                                                    1.99214
  AB173728           gi\|111154086\|ref\|NM_020631.3 *Homo sapiens* pleckstrin homology domain-containing, family G (with RhoGef domain) member 5 (PLEKHG5), transcript variant 1, mRNA                  1.98959
  DC647709           gi\|28416926\|ref\|NM_002560.2 *Homo sapiens* purinergic receptor P2X, ligand-gated ion channel, 4 (P2RX4), mRNA                                                                    1.98692
  AB048919           gi\|156766083\|ref\|NM_031418.2 *Homo sapiens* anoctamin 3 (ANO3), mRNA                                                                                                             1.98684
  AB179103           gi\|18860913\|ref\|NM_021818.2 *Homo sapiens* salvador homolog 1 (*Drosophila*) (SAV1), mRNA                                                                                        1.97681
  AB046073           gi\|118498342\|ref\|NM_014861.2 *Homo sapiens* ATPase, Ca^++^ transporting, type 2C, member 2 (ATP2C2), mRNA                                                                        1.97604
  AB172144           gi\|190341103\|ref\|NM_015163.5 *Homo sapiens* tripartite motif-containing 9 (TRIM9), transcript variant 1, mRNA                                                                    1.97599
  DK583369           gi\|171460955\|ref\|NM_005800.4 *Homo sapiens* ubiquitin-specific peptidase like 1 (USPL1), mRNA                                                                                    1.9752
  AB174098           gi\|110815799\|ref\|NM_024345.3 *Homo sapiens* DDB1 and CUL4-associated factor 10 (DCAF10), mRNA                                                                                    1.97309
  DW526268           gi\|31083173\|ref\|NM_181078.1 *Homo sapiens* interleukin 21 receptor (IL21R), transcript variant 2, mRNA                                                                           1.97258
  AB171701           gi\|20544144\|ref\|NM_139062.1 *Homo sapiens* casein kinase 1, delta (CSNK1D), transcript variant 2, mRNA                                                                           1.96537
  CJ493302           gi\|17136150\|ref\|NM_004724.2 *Homo sapiens* ZW10, kinetochore associated, homolog (*Drosophila*) (ZW10), mRNA                                                                     1.96534
  DK577545           gi\|24797075\|ref\|NM_002121.4 *Homo sapiens* major histocompatibility complex, class II, DP beta 1 (HLA-DPB1), mRNA                                                                1.96346
  CJ458429           gi\|71067335\|ref\|NM_031462.2 *Homo sapiens* CD99 molecule-like 2 (CD99L2), transcript variant 1, mRNA                                                                             1.96208
  AB172752           gi\|32698785\|ref\|NM_182490.1 *Homo sapiens* zinc finger protein 227 (ZNF227), mRNA                                                                                                1.95671
  AB171668           gi\|40385866\|ref\|NM_199227.1 *Homo sapiens* methionine aminopeptidase 1D (MAP1D), mRNA                                                                                            1.95399
  AB051117           gi\|82617625\|ref\|NM_001037293.1 *Homo sapiens* paralemmin 2 (PALM2), transcript variant 2, mRNA                                                                                   1.9528
  AB169059           gi\|91992151\|ref\|NM_000616.3 *Homo sapiens* CD4 molecule (CD4), mRNA                                                                                                              1.95226
  CJ443230           gi\|46094085\|ref\|NM_022758.4 *Homo sapiens* chromosome 6 open reading frame 106 (C6orf106), transcript variant 2, mRNA                                                            1.95082
  AB178987           gi\|38045951\|ref\|NM_021030.2 *Homo sapiens* zinc finger protein 14 (ZNF14), mRNA                                                                                                  1.94816
  AB172387           gi\|163659919\|ref\|NM_052839.3 *Homo sapiens* pannexin 2 (PANX2), transcript variant 1, mRNA                                                                                       1.94536
  AB168775           gi\|223468671\|ref\|NM_001145135.1 *Homo sapiens* carnitine palmitoyltransferase 1B (muscle) (CPT1B), nuclear gene encoding mitochondrial protein, transcript variant 6, mRNA       1.94062
  DC633198           gi\|206725531\|ref\|NM_001826.2 *Homo sapiens* CDC28 protein kinase regulatory subunit 1B (CKS1B), transcript variant 1, mRNA                                                       1.93773
  AB172044           gi\|25168266\|ref\|NM_170709.1 *Homo sapiens* serum/glucocorticoid-regulated kinase family, member 3 (SGK3), transcript variant 2, mRNA                                             1.93543
  DK578185           gi\|239754745\|ref\|XM_002346052.1 PREDICTED: *Homo sapiens* hypothetical protein LOC100293771 (LOC100293771), mRNA                                                                 1.93421
  AB171597           gi\|113951732\|ref\|NM_012095.4 *Homo sapiens* adaptor-related protein complex 3, mu 1 subunit (AP3M1), transcript variant 2, mRNA                                                  1.93313
  AB179405           gi\|31543301\|ref\|NM_032600.2 *Homo sapiens* coiled-coil domain-containing 54 (CCDC54), mRNA                                                                                       1.93038
  AB179267           gi\|37594443\|ref\|NM_015896.2 *Homo sapiens* zinc finger, MYND-type-containing 10 (ZMYND10), mRNA                                                                                  1.92859
  DC640525           gi\|35493837\|ref\|NM_004902.2 *Homo sapiens* RNA-binding motif protein 39 (RBM39), transcript variant 2, mRNA                                                                      1.92337
  AB049869           gi\|239753181\|ref\|XM_002345525.1 PREDICTED: *Homo sapiens* similar to hCG2041348 (LOC100293610), mRNA                                                                             1.92159
  DW528250           gi\|52487034\|ref\|NM_004618.3 *Homo sapiens* topoisomerase (DNA) III alpha (TOP3A), mRNA                                                                                           1.91924
  DC636463           gi\|78214521\|ref\|NM_001035258.1 *Homo sapiens* ribosomal protein L38 (RPL38), transcript variant 2, mRNA                                                                          1.91826
  AB179052           gi\|115511031\|ref\|NM_004432.2 *Homo sapiens* ELAV- (embryonic lethal, abnormal vision, *Drosophila*-) like 2 (Hu antigen B) (ELAVL2), mRNA                                        1.91696
  AB168809           gi\|37622352\|ref\|NM_003551.2 *Homo sapiens* nonmetastatic cells 5, protein expressed in nucleoside-diphosphate kinase (NME5), mRNA                                                1.91336
  CJ435007           gi\|115527063\|ref\|NM_004859.3 *Homo sapiens* clathrin, heavy chain (Hc) (CLTC), mRNA                                                                                              1.91318
  AB171499           gi\|50845406\|ref\|NM_031444.2 *Homo sapiens* chromosome 22 open reading frame 13 (C22orf13), mRNA                                                                                  1.91088
  DC647333           gi\|118600974\|ref\|NM_007269.2 *Homo sapiens* syntaxin-binding protein 3 (STXBP3), mRNA                                                                                            1.90575
  AB172403           gi\|142976637\|ref\|NM_017420.3 *Homo sapiens* SIX homeobox 4 (SIX4), mRNA                                                                                                          1.89362
  AB174282           gi\|31543080\|ref\|NM_016210.2 *Homo sapiens* chromosome 3 open reading frame 18 (C3orf18), mRNA                                                                                    1.89271
  DC648759           gi\|6382072\|ref\|NM_005258.2 *Homo sapiens* GTP cyclohydrolase I feedback regulator (GCHFR), mRNA                                                                                  1.88951
  AB169033           gi\|195927038\|ref\|NM_001786.3 *Homo sapiens* cell division cycle 2, G1 to S and G2 to M (CDC2), transcript variant 1, mRNA                                                        1.88515
  AB173309           gi\|209447072\|ref\|NM_001135806.1 *Homo sapiens* synaptotagmin I (SYT1), transcript variant 3, mRNA                                                                                1.88194
  AB063003           gi\|116063563\|ref\|NM_018218.2 *Homo sapiens* ubiquitin-specific peptidase 40 (USP40), mRNA                                                                                        1.88102
  AB171041           gi\|86787650\|ref\|NM_014800.9 *Homo sapiens* engulfment and cell motility 1 (ELMO1), transcript variant 1, mRNA                                                                    1.87945
  CJ470094           gi\|209364624\|ref\|NM_001822.4 *Homo sapiens* chimerin (chimaerin) 1 (CHN1), transcript variant 1, mRNA                                                                            1.87132
  AB171236           gi\|19743893\|ref\|NM_133480.1 *Homo sapiens* transcriptional adaptor 3 (NGG1 homolog, yeast)-like (TADA3L), transcript variant 2, mRNA                                             1.86897
  BB885210           gi\|32484974\|ref\|NM_006721.2 *Homo sapiens* adenosine kinase (ADK), transcript variant ADK-long, mRNA                                                                             1.86865
  AB169067           gi\|188528615\|ref\|NM_182911.3 *Homo sapiens* testis-specific, 10 (TSGA10), transcript variant 2, mRNA                                                                             1.86706
  CJ464698           gi\|221307560\|ref\|NR_026669.1 *Homo sapiens* synaptosomal-associated protein, 91 kDa homolog (mouse) (SNAP91), transcript variant 2, transcribed RNA                              1.86542
  AB179482           gi\|51173716\|ref\|NM_006720.3 *Homo sapiens* actin-binding LIM protein 1 (ABLIM1), transcript variant 4, mRNA                                                                      1.85972
  CJ442615           gi\|239745120\|ref\|XR_015162.2 PREDICTED: *Homo sapiens* hypothetical protein LOC727880 (LOC727880), miscRNA                                                                       1.85021
  CJ435208           gi\|170650722\|ref\|NM_014236.3 *Homo sapiens* glyceronephosphate O-acyltransferase (GNPAT), mRNA                                                                                   1.8499
  AY650307           gi\|51599155\|ref\|NM_001273.2 *Homo sapiens* chromodomain helicase DNA-binding protein 4 (CHD4), mRNA                                                                              1.84509
  DW525872           gi\|77404354\|ref\|NM_003908.3 *Homo sapiens* eukaryotic translation initiation factor 2, subunit 2 beta, 38 kDa (EIF2S2), mRNA                                                     1.84501
  DW529999           gi\|78190459\|ref\|NM_000978.3 *Homo sapiens* ribosomal protein L23 (RPL23), mRNA                                                                                                   1.84409
  AB174451           gi\|223941821\|ref\|NM_014342.3 *Homo sapiens* mitochondrial carrier homolog 2 (*C. elegans*) (MTCH2), nuclear gene encoding mitochondrial protein, mRNA                            1.84017
  AB066534           gi\|188528627\|ref\|NM_033109.3 *Homo sapiens* polyribonucleotide nucleotidyltransferase 1 (PNPT1), mRNA                                                                            1.83655
  BB888999           gi\|160298191\|ref\|NM_000507.3 *Homo sapiens* fructose-1,6-bisphosphatase 1 (FBP1), transcript variant 1, mRNA                                                                     1.8352
  DC637318           gi\|209977038\|ref\|NM_016074.3 *Homo sapiens* bolA homolog 1 (*E. coli*) (BOLA1), mRNA                                                                                             1.83477
  AB169205           gi\|109948303\|ref\|NM_018225.2 *Homo sapiens* smu-1 suppressor of mec-8 and unc-52 homolog (*C. elegans*) (SMU1), mRNA                                                             1.82627
  CJ441961           gi\|19913444\|ref\|NM_016257.2 *Homo sapiens* hippocalcin-like 4 (HPCAL4), mRNA                                                                                                     1.8159
  AY650384           gi\|141803509\|ref\|NM_058164.2 *Homo sapiens* olfactomedin 2 (OLFM2), mRNA                                                                                                         1.81587
  DC647305           gi\|38372918\|ref\|NM_001728.2 *Homo sapiens* basigin (Ok blood group) (BSG), transcript variant 1, mRNA                                                                            1.8093
  AB172260           gi\|112382251\|ref\|NM_178313.2 *Homo sapiens* spectrin, beta, nonerythrocytic 1 (SPTBN1), transcript variant 2, mRNA                                                               1.80742
  AB173850           gi\|194097340\|ref\|NM_002616.2 *Homo sapiens* period homolog 1 (*Drosophila*) (PER1), mRNA                                                                                         1.80415
  AB168762           gi\|242247096\|ref\|NM_001340.3 *Homo sapiens* cylicin, basic protein of sperm head cytoskeleton 2 (CYLC2), mRNA                                                                    1.80079
  AB173856           gi\|60302919\|ref\|NM_001752.2 *Homo sapiens* catalase (CAT), mRNA                                                                                                                  1.79676
  AB060862           gi\|221219051\|ref\|NM_031924.4 *Homo sapiens* radial spoke 3 homolog (*Chlamydomonas*) (RSPH3), mRNA                                                                               1.79563
  CJ470793           gi\|224586819\|ref\|NR_027265.1 *Homo sapiens* Golgi apparatus protein 1 (GLG1), transcript variant 5, transcribed RNA                                                              1.79405
  DW528583           gi\|239787833\|ref\|NM_015139.2 *Homo sapiens* solute carrier family 35 (UDP-glucuronic acid/UDP-N-acetylgalactosamine dual transporter), member D1 (SLC35D1), mRNA                 1.79359
  DK580881           gi\|194394144\|ref\|NM_145870.2 *Homo sapiens* glutathione transferase zeta 1 (GSTZ1), transcript variant 1, mRNA                                                                   1.792
  AB173997           gi\|225543100\|ref\|NR_027378.1 *Homo sapiens* hypothetical LOC643763 (LOC643763), noncoding RNA                                                                                    1.79131
  AY650356           gi\|223718142\|ref\|NM_173054.2 *Homo sapiens* reelin (RELN), transcript variant 2, mRNA                                                                                            1.78729
  DK584117           gi\|15967154\|ref\|NM_016558.2 *Homo sapiens* SCAN domain-containing 1 (SCAND1), transcript variant 1, mRNA                                                                         1.78008
  DC621384           gi\|15431296\|ref\|NM_000977.2 *Homo sapiens* ribosomal protein L13 (RPL13), transcript variant 1, mRNA                                                                             1.77763
  DK577712           gi\|109148541\|ref\|NM_001605.2 *Homo sapiens* alanyl-tRNA synthetase (AARS), mRNA                                                                                                  1.77723
  AB174251           gi\|253314435\|ref\|NR_027995.1 *Homo sapiens* ankyrin repeat domain 20 family, member A2 pseudogene (LOC284232), noncoding RNA                                                     1.77027
  AB174247           gi\|50897295\|ref\|NM_001002923.1 *Homo sapiens* IGF-like family member 4 (IGFL4), mRNA                                                                                             1.76977
  CJ490195           gi\|78190459\|ref\|NM_000978.3 *Homo sapiens* ribosomal protein L23 (RPL23), mRNA                                                                                                   1.76786
  AB171831           gi\|167466275\|ref\|NM_152542.3 *Homo sapiens* protein phosphatase 1K (PP2C domain containing) (PPM1K), mRNA                                                                        1.76709
  DK582810           gi\|90652856\|ref\|NM_032818.2 *Homo sapiens* chromosome 9 open reading frame 100 (C9orf100), mRNA                                                                                  1.765
  AB170534           gi\|108773786\|ref\|NM_000321.2 *Homo sapiens* retinoblastoma 1 (RB1), mRNA                                                                                                         1.76182
  AB171096           gi\|110347436\|ref\|NM_001042545.1 *Homo sapiens* latent transforming growth factor beta-binding protein 4 (LTBP4), transcript variant 3, mRNA                                      1.75594
  AB168611           gi\|21071068\|ref\|NM_004865.2 *Homo sapiens* TBP-like 1 (TBPL1), mRNA                                                                                                              1.74839
  CJ492188           gi\|30181234\|ref\|NM_003447.2 *Homo sapiens* zinc finger protein 165 (ZNF165), mRNA                                                                                                1.74573
  AB171700           gi\|115527063\|ref\|NM_004859.3 *Homo sapiens* clathrin, heavy chain (Hc) (CLTC), mRNA                                                                                              1.74566
  AB171366           gi\|22748942\|ref\|NM_152445.1 *Homo sapiens* family with sequence similarity 161, member B (FAM161B), mRNA                                                                         1.74405
  AB168566           gi\|148664196\|ref\|NM_017950.2 *Homo sapiens* coiled-coil domain-containing 40 (CCDC40), mRNA                                                                                      1.74135
  AB171657           gi\|221316692\|ref\|NM_198449.2 *Homo sapiens* embigin homolog (mouse) (EMB), mRNA                                                                                                  1.73933
  AB056808           gi\|71772767\|ref\|NM_152826.2 *Homo sapiens*-sorting nexin 1 (SNX1), transcript variant 3, mRNA                                                                                    1.73686
  AB168849           gi\|156766042\|ref\|NM_001103146.1 *Homo sapiens* GRB10-interacting GYF protein 2 (GIGYF2), transcript variant 3, mRNA                                                              1.73412
  AB172848           gi\|95113665\|ref\|NM_018157.2 *Homo sapiens* resistance to inhibitors of cholinesterase 8 homolog B (*C. elegans*) (RIC8B), mRNA                                                   1.72749
  AB048894           gi\|148727250\|ref\|NM_007137.2 *Homo sapiens* zinc finger protein 81 (ZNF81), mRNA                                                                                                 1.71845
  DW524469           gi\|239753181\|ref\|XM_002345525.1 PREDICTED: *Homo sapiens* similar to hCG2041348 (LOC100293610), mRNA                                                                             1.71582
  AB173566           gi\|89242130\|ref\|NM_014305.2 *Homo sapiens* TDP-glucose 4,6-dehydratase (TGDS), mRNA                                                                                              1.71406
  DC634783           gi\|116812576\|ref\|NM_016019.2 *Homo sapiens* LUC7-like 2 (*S. cerevisiae*) (LUC7L2), mRNA                                                                                         1.71163
  AB168438           gi\|64276485\|ref\|NM_005869.2 *Homo sapiens* serologically defined colon cancer antigen 10 (SDCCAG10), mRNA                                                                        1.71108
  AB174725           gi\|169194555\|ref\|XR_040716.1 PREDICTED: *Homo sapiens* hypothetical LOC439950 (LOC439950), miscRNA                                                                               1.70933
  AB170786           gi\|208879448\|ref\|NM_006265.2 *Homo sapiens* RAD21 homolog (*S. pombe*) (RAD21), mRNA                                                                                             1.70551
  CJ431422           gi\|117938253\|ref\|NM_001077441.1 *Homo sapiens* BCL2-associated transcription factor 1 (BCLAF1), transcript variant 3, mRNA                                                       1.70446
  AB048954           gi\|148596971\|ref\|NM_014951.2 *Homo sapiens* zinc finger protein 365 (ZNF365), transcript variant A, mRNA                                                                         1.70334
  AB173447           gi\|40288292\|ref\|NM_000361.2 *Homo sapiens* thrombomodulin (THBD), mRNA                                                                                                           1.70293
  AB173287           gi\|242117988\|ref\|NM_014702.4 *Homo sapiens* KIAA0408 (KIAA0408), mRNA                                                                                                            1.70162
  CJ489820           gi\|218505834\|ref\|NM_001142782.1 *Homo sapiens* membrane-associated guanylate kinase, WW, and PDZ domain-containing 3 (MAGI3), transcript variant 1, mRNA                         1.68381
  AB173372           gi\|78190481\|ref\|NM_025221.5 *Homo sapiens* Kv channel-interacting protein 4 (KCNIP4), transcript variant 1, mRNA                                                                 1.68058
  AB172865           gi\|31795545\|ref\|NM_012450.2 *Homo sapiens* solute carrier family 13 (sodium/sulfate symporters), member 4 (SLC13A4), mRNA                                                        1.67878
  AB168329           gi\|223468562\|ref\|NM_005628.2 *Homo sapiens* solute carrier family 1 (neutral amino acid transporter), member 5 (SLC1A5), transcript variant 1, mRNA                              1.67642
  AB171546           gi\|55956903\|ref\|NM_005922.2 *Homo sapiens* mitogen-activated protein kinase kinase kinase 4 (MAP3K4), transcript variant 1, mRNA                                                 1.67151
  AB063093           gi\|194248055\|ref\|NM_002045.3 *Homo sapiens* growth-associated protein 43 (GAP43), transcript variant 2, mRNA                                                                     1.66805
  AB220449           gi\|23510394\|ref\|NM_138966.2 *Homo sapiens* neuropilin- (NRP-) and tolloid- (TLL-) like 1 (NETO1), transcript variant 3, mRNA                                                     1.66789
  AB169208           gi\|22547155\|ref\|NM_002018.2 *Homo sapiens* flightless I homolog (*Drosophila*) (FLII), mRNA                                                                                      1.66361
  AB168324           gi\|116014337\|ref\|NM_030981.2 *Homo sapiens* RAB1B, member RAS oncogene family (RAB1B), mRNA                                                                                      1.66298
  AB169835           gi\|50726964\|ref\|NM_013392.2 *Homo sapiens* nuclear receptor-binding protein 1 (NRBP1), mRNA                                                                                      1.65785
  AB173501           gi\|195539333\|ref\|NM_018176.3 *Homo sapiens* leucine-rich repeat LGI family, member 2 (LGI2), mRNA                                                                                1.6574
  DC630946           gi\|183227689\|ref\|NM_002049.3 *Homo sapiens* GATA-binding protein 1 (globin transcription factor 1) (GATA1), mRNA                                                                 1.65657
  AB063075           gi\|239743824\|ref\|XM_001128647.3 PREDICTED: *Homo sapiens* hypothetical LOC728701 (LOC728701), mRNA                                                                               1.65564
  AB169782           gi\|38261964\|ref\|NM_198399.1 *Homo sapiens* cyclic AMP-regulated phosphoprotein, 21 kD (ARPP-21), transcript variant 2, mRNA                                                      1.65067
  CJ477467           gi\|133778911\|ref\|NM_003309.2 *Homo sapiens* TSPY-like 1 (TSPYL1), mRNA                                                                                                           1.65062
  BB900725           gi\|31542685\|ref\|NM_025125.2 *Homo sapiens* chromosome 10 open reading frame 57 (C10orf57), mRNA                                                                                  1.64409
  AB220555           gi\|208973250\|ref\|NM_003702.3 *Homo sapiens* regulator of G-protein signaling 20 (RGS20), transcript variant 2, mRNA                                                              1.64376
  AB171804           gi\|66932910\|ref\|NM_014676.2 *Homo sapiens* pumilio homolog 1 (*Drosophila*) (PUM1), transcript variant 2, mRNA                                                                   1.63724
  DC625559           gi\|4557320\|ref\|NM_000039.1 *Homo sapiens* apolipoprotein A-I (APOA1), mRNA                                                                                                       1.631
  AB172266           gi\|170932491\|ref\|NM_030770.2 *Homo sapiens* transmembrane protease, serine 5 (TMPRSS5), mRNA                                                                                     1.62995
  AB173763           gi\|62953115\|ref\|NM_001017523.1 *Homo sapiens* BTB (POZ) domain-containing 11 (BTBD11), transcript variant b, mRNA                                                                1.62499
  AB172974           gi\|111161293\|ref\|NM_005746.2 *Homo sapiens* nicotinamide phosphoribosyltransferase (NAMPT), mRNA                                                                                 1.62078
  AB179155           gi\|187608347\|ref\|NM_145046.3 *Homo sapiens* calreticulin 3 (CALR3), mRNA                                                                                                         1.6111
  AB169148           gi\|153792481\|ref\|NM_033048.4 *Homo sapiens* CPX chromosome region, candidate 1 (CPXCR1), mRNA                                                                                    1.60985
  AB171264           gi\|130977817\|ref\|NM_024549.4 *Homo sapiens* tectonic family member 1 (TCTN1), transcript variant 3, mRNA                                                                         1.60704
  AB172446           gi\|193083128\|ref\|NM_001128920.1 *Homo sapiens* MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4, mRNA                                                  1.60471
  DC852298           gi\|195972796\|ref\|NM_001130917.1 *Homo sapiens* leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 (LILRA2), transcript variant 1, mRNA               1.59852
  AB046637           gi\|209571546\|ref\|NM_018095.4 *Homo sapiens* Kelch repeat and BTB (POZ) domain-containing 4 (KBTBD4), transcript variant 1, mRNA                                                  1.58107
  CJ445723           gi\|90903230\|ref\|NM_002111.6 *Homo sapiens* huntingtin (HTT), mRNA                                                                                                                1.57689
  DC630899           gi\|83641894\|ref\|NM_031157.2 *Homo sapiens* heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1), transcript variant 2, mRNA                                                      1.5766
  AB168476           gi\|219555742\|ref\|NM_015335.3 *Homo sapiens* mediator complex subunit 13-like (MED13L), mRNA                                                                                      1.57355
  DC642541           gi\|20357546\|ref\|NM_004231.2 *Homo sapiens* ATPase, H+ transporting, lysosomal 14 kDa, V1 subunit F (ATP6V1F), mRNA                                                               1.57215
  AB170370           gi\|224177554\|ref\|NM_002340.5 *Homo sapiens* lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) (LSS), transcript variant 1, mRNA                                         1.57006
  DC636538           gi\|71164876\|ref\|NM_001014.3 *Homo sapiens* ribosomal protein S10 (RPS10), mRNA                                                                                                   1.56413
  DC648258           gi\|4557818\|ref\|NM_000277.1 *Homo sapiens* phenylalanine hydroxylase (PAH), mRNA                                                                                                  1.56396
  AB168688           gi\|75709218\|ref\|NM_001324.2 *Homo sapiens* cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50 kDa (CSTF1), transcript variant 2, mRNA                                        1.56349
  CJ486539           gi\|194018543\|ref\|NM_031451.4 *Homo sapiens* testis expressed 101 (TEX101), transcript variant 1, mRNA                                                                            1.55338
  AB173591           gi\|56699472\|ref\|NM_006298.2 *Homo sapiens* zinc finger protein 192 (ZNF192), mRNA                                                                                                1.54892
  AB168460           gi\|56090619\|ref\|NM_001007531.1 *Homo sapiens* NFKB-activating protein-like (NKAPL), mRNA                                                                                         1.54807
  AB046102           gi\|215272394\|ref\|NM_001080475.2 *Homo sapiens* pleckstrin homology domain containing, family M, member 3 (PLEKHM3), mRNA                                                         1.53926
  AB097526           gi\|46409303\|ref\|NM_207332.1 *Homo sapiens* glutamate-rich 1 (ERICH1), mRNA                                                                                                       1.53642
  AB052134           gi\|227430412\|ref\|NM_024827.3 *Homo sapiens* histone deacetylase 11 (HDAC11), transcript variant 1, mRNA                                                                          1.53543
  AB170181           gi\|21265090\|ref\|NM_007208.2 *Homo sapiens* mitochondrial ribosomal protein L3 (MRPL3), nuclear gene encoding mitochondrial protein, mRNA                                         1.52903
  AB171241           gi\|116235443\|ref\|NM_138421.2 *Homo sapiens* serum amyloid A-like 1 (SAAL1), mRNA                                                                                                 1.52713
  AB171237           gi\|48675815\|ref\|NM_015723.2 *Homo sapiens* patatin-like phospholipase domain-containing 8 (PNPLA8), mRNA                                                                         1.52587
  DC625517           gi\|47578120\|ref\|NM_177947.2 *Homo sapiens* armadillo repeat containing, X-linked 3 (ARMCX3), transcript variant 2, mRNA                                                          1.52547
  AB168964           gi\|87159814\|ref\|NM_001696.3 *Homo sapiens* ATPase, H+ transporting, lysosomal 31 kDa, V1 subunit E1 (ATP6V1E1), transcript variant 1, mRNA                                       1.52424
  DC631115           gi\|239752151\|ref\|XM_002348112.1 PREDICTED: *Homo sapiens* similar to immunoglobulin lambda locus (LOC100290481), mRNA                                                            1.51711
  DC640134           gi\|208609986\|ref\|NM_014655.2 *Homo sapiens* solute carrier family 25, member 44 (SLC25A44), transcript variant 1, mRNA                                                           1.51672
  AB173691           gi\|94536855\|ref\|NM_013301.2 *Homo sapiens* coiled-coil domain-containing 106 (CCDC106), mRNA                                                                                     1.50477
  AB168370           gi\|154744869\|ref\|NM_022752.5 *Homo sapiens* zinc finger protein 574 (ZNF574), mRNA                                                                                               1.50452

###### 

Genes that are downregulated in TM cells.

  Accession number   Human RefSeq description                                                                                                                                                                   Fold change
  ------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------
  DC624859           gi\|215982788\|ref\|NM_000477.5 *Homo sapiens* albumin (ALB), mRNA                                                                                                                         0.11952
  AB171761           gi\|148271103\|ref\|NM_173495.2 *Homo sapiens* patched domain-containing 1 (PTCHD1), mRNA                                                                                                  0.13543
  AB047615           gi\|70780382\|ref\|NM_004285.3 *Homo sapiens* hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (H6PD), mRNA                                                                      0.17649
  DC621007           gi\|38016905\|ref\|NR_001578.1 *Homo sapiens* L-threonine dehydrogenase (TDH), noncoding RNA                                                                                               0.20061
  CJ443677           gi\|38327038\|ref\|NM_002154.3 *Homo sapiens* heat shock 70 kDa protein 4 (HSPA4), mRNA                                                                                                    0.2086
  DC622138           gi\|145386530\|ref\|NM_001084392.1 *Homo sapiens* D-dopachrome tautomerase (DDT), transcript variant 2, mRNA                                                                               0.21345
  BB891761           gi\|33519462\|ref\|NM_004544.2 *Homo sapiens* NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42 kDa (NDUFA10), nuclear gene encoding mitochondrial protein, mRNA                  0.23147
  CJ444181           gi\|226437566\|ref\|NM_001018060.2 *Homo sapiens* apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3), nuclear gene encoding mitochondrial protein, transcript variant 2, mRNA   0.24045
  AB171890           gi\|118572602\|ref\|NM_001079514.1 *Homo sapiens* ubinuclein 1 (UBN1), transcript variant 2, mRNA                                                                                          0.24676
  AB174511           gi\|153792041\|ref\|NM_020823.1 *Homo sapiens* transmembrane protein 181 (TMEM181), mRNA                                                                                                   0.29472
  AB168319           gi\|116256484\|ref\|NM_006781.3 *Homo sapiens* chromosome 6 open reading frame 10 (C6orf10), mRNA                                                                                          0.3105
  DW526909           gi\|20302159\|ref\|NM_005999.2 *Homo sapiens* translin-associated factor X (TSNAX), mRNA                                                                                                   0.32949
  AB173471           gi\|154354995\|ref\|NM_002222.4 *Homo sapiens* inositol 1,4,5-triphosphate receptor, type 1 (ITPR1), transcript variant 2, mRNA                                                            0.33892
  BB898986           gi\|167003944\|ref\|NM_000204.3 *Homo sapiens* complement factor I (CFI), mRNA                                                                                                             0.34234
  DK578390           gi\|56788350\|ref\|NM_001008695.1 *Homo sapiens* THAP domain-containing 7 (THAP7), transcript variant 2, mRNA                                                                              0.35502
  CJ444326           gi\|209413724\|ref\|NM_003692.3 *Homo sapiens* transmembrane protein with EGF-like and two follistatin-like domains 1 (TMEFF1), mRNA                                                       0.3719
  AB048874           gi\|239753181\|ref\|XM_002345525.1 PREDICTED: *Homo sapiens* similar to hCG2041348 (LOC100293610), mRNA                                                                                    0.38524
  DC635743           gi\|239750740\|ref\|XM_002347480.1 PREDICTED: *Homo sapiens* similar to hCG2038941 (LOC100290006), mRNA                                                                                    0.3882
  CJ442045           gi\|96975096\|ref\|NM_016577.3 *Homo sapiens* RAB6B, member RAS oncogene family (RAB6B), mRNA                                                                                              0.39034
  BB897881           gi\|31542685\|ref\|NM_025125.2 *Homo sapiens* chromosome 10 open reading frame 57 (C10orf57), mRNA                                                                                         0.39308
  AB168422           gi\|194306536\|ref\|NM_144594.2 *Homo sapiens* gametocyte-specific factor 1 (GTSF1), mRNA                                                                                                  0.43061
  DW524779           gi\|226342870\|ref\|NR_027449.1 *Homo sapiens* TBC1 domain family, member 15 (TBC1D15), transcript variant 4, transcribed RNA                                                              0.44075
  DC630545           gi\|39812105\|ref\|NM_198941.1 *Homo sapiens* serine incorporator 3 (SERINC3), transcript variant 2, mRNA                                                                                  0.44508
  AB172901           gi\|42544225\|ref\|NM_020857.2 *Homo sapiens* vacuolar protein sorting 18 homolog (*S. cerevisiae*) (VPS18), mRNA                                                                          0.44872
  DW528888           gi\|40068463\|ref\|NM_020732.2 *Homo sapiens* AT-rich interactive domain 1B (SWI1-like) (ARID1B), transcript variant 2, mRNA                                                               0.44985
  DC636880           gi\|17738314\|ref\|NM_006835.2 *Homo sapiens* cyclin I (CCNI), mRNA                                                                                                                        0.45196
  AB220379           gi\|185134767\|ref\|NM_002524.3 *Homo sapiens* neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS), mRNA                                                                               0.46121
  AB055316           gi\|226437631\|ref\|NM_001004339.2 *Homo sapiens* zyg-11 homolog A (*C. elegans*) (ZYG11A), mRNA                                                                                           0.46399
  DC641070           gi\|58331227\|ref\|NM_005223.3 *Homo sapiens* deoxyribonuclease I (DNASE1), mRNA                                                                                                           0.46575
  AB056428           gi\|49574533\|ref\|NM_032782.3 *Homo sapiens* hepatitis A virus cellular receptor 2 (HAVCR2), mRNA                                                                                         0.46705
  AB168577           gi\|146260272\|ref\|NM_001085451.1 *Homo sapiens* leukemia NUP98 fusion partner 1 (LNP1), mRNA                                                                                             0.46891
  AB048999           gi\|225735571\|ref\|NR_027416.1 *Homo sapiens* nuclear factor erythroid-derived 2-like 3 pseudogene (LOC100272146), noncoding RNA                                                          0.47824
  AB174085           gi\|142360382\|ref\|NM_176815.3 *Homo sapiens* dihydrofolate reductase-like 1 (DHFRL1), mRNA                                                                                               0.49049
  DC642335           gi\|148491081\|ref\|NM_001343.2 *Homo sapiens*-disabled homolog 2, mitogen-responsive phosphoprotein (*Drosophila*) (DAB2), mRNA                                                           0.4971
  AB173771           gi\|38176290\|ref\|NM_001233.3 *Homo sapiens* caveolin 2 (CAV2), transcript variant 1, mRNA                                                                                                0.49863
  DW523198           gi\|145312264\|ref\|NM_033266.3 *Homo sapiens* endoplasmic reticulum to nucleus signaling 2 (ERN2), mRNA                                                                                   0.50158
  AF492282           gi\|52630343\|ref\|NM_021983.4 *Homo sapiens* major histocompatibility complex, class II, DR beta 4 (HLA-DRB4), mRNA                                                                       0.50533
  AB047937           gi\|194097480\|ref\|NM_020412.4 *Homo sapiens* chromatin-modifying protein 1B (CHMP1B), mRNA                                                                                               0.51198
  AB179165           gi\|118136291\|ref\|NM_006465.2 *Homo sapiens* AT-rich interactive domain 3B (bright-like) (ARID3B), mRNA                                                                                  0.51349
  AJ585530           gi\|75709168\|ref\|NM_002260.3 *Homo sapiens* killer cell lectin-like receptor subfamily C, member 2 (KLRC2), mRNA                                                                         0.52335
  AB170944           gi\|40255250\|ref\|NM_144635.3 *Homo sapiens* family with sequence similarity 131, member A (FAM131A), mRNA                                                                                0.55244
  AB171281           gi\|154759258\|ref\|NM_003127.2 *Homo sapiens* spectrin, alpha, nonerythrocytic 1 (alpha-fodrin) (SPTAN1), transcript variant 2, mRNA                                                      0.555
  AB172429           gi\|224994204\|ref\|NM_001145853.1 *Homo sapiens* Wolfram syndrome 1 (wolframin) (WFS1), transcript variant 2, mRNA                                                                        0.57755
  AB171421           gi\|110611175\|ref\|NM_000843.3 *Homo sapiens* glutamate receptor, metabotropic 6 (GRM6), mRNA                                                                                             0.58226
  AB096987           gi\|239750853\|ref\|XR_079356.1 PREDICTED: *Homo sapiens* hypothetical protein LOC100130855 (LOC100130855), miscRNA                                                                        0.59997
  AB049000           gi\|209977116\|ref\|NM_080872.2 *Homo sapiens* unc-5 homolog D (*C. elegans*) (UNC5D), mRNA                                                                                                0.60066
  BB893759           gi\|194018407\|ref\|NM_178148.2 *Homo sapiens* solute carrier family 35, member B2 (SLC35B2), mRNA                                                                                         0.61849
  AB056791           gi\|162951883\|ref\|NM_014925.3 *Homo sapiens* R3H domain-containing 2 (R3HDM2), mRNA                                                                                                      0.64652
  AB070176           gi\|221307501\|ref\|NM_001143976.1 *Homo sapiens* WEE1 homolog (*S. pombe*) (WEE1), transcript variant 2, mRNA                                                                             0.64704
  AB048962           gi\|154146186\|ref\|NM_152634.2 *Homo sapiens* transcription elongation factor A (SII) N-terminal and central domain containing (TCEANC), mRNA                                             0.65673
  DK578501           gi\|24797073\|ref\|NM_033554.2 *Homo sapiens* major histocompatibility complex, class II, DP alpha 1 (HLA-DPA1), mRNA                                                                      0.65963

###### 

Gene ontology of upregulated genes in Y-27632-treated TM cells.

  Ontology             Term                                                                                                                                                                             Changed genes   Total genes   *P* value
  -------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------- ------------- -----------
  Cellular component   Cell projection                                                                                                                                                                  31 (1)          331 (38)      0.0000306
  Cellular component   Neuron projection                                                                                                                                                                20 (6)          180 (28)      0.0000901
  Cellular component   Cell projection part                                                                                                                                                             17 (0)          142 (0)       0.000135
  Biological process   Regulation of neurotransmitter levels                                                                                                                                            8 (0)           47 (2)        0.00148
  Molecular function   Calcium channel regulator activity                                                                                                                                               4 (3)           11 (9)        0.00225
  Cellular component   Presynaptic membrane                                                                                                                                                             5 (5)           20 (20)       0.0024
  Cellular component   Plasma membrane part                                                                                                                                                             45 (0)          706 (2)       0.00259
  Biological process   Synaptic transmission                                                                                                                                                            16 (10)         170 (66)      0.00374
  Molecular function   Channel regulator activity                                                                                                                                                       5 (0)           23 (0)        0.00421
  Biological process   Cellular nitrogen compound biosynthetic process                                                                                                                                  21 (0)          255 (0)       0.00443
  Biological process   L-Glutamate import                                                                                                                                                               3 (3)           6 (4)         0.00456
  Cellular component   Platelet alpha granule                                                                                                                                                           5 (1)           24 (2)        0.00472
  Biological process   Transmission of nerve impulse                                                                                                                                                    17 (0)          189 (3)       0.00563
  Molecular function   Anion:cation symporter activity                                                                                                                                                  4 (0)           15 (0)        0.00565
  Molecular function   Sodium:dicarboxylate symporter activity                                                                                                                                          3 (3)           7 (7)         0.00585
  Biological process   L-Amino acid import                                                                                                                                                              3 (0)           7 (0)         0.00632
  Biological process   Amino acid import                                                                                                                                                                3 (0)           7 (0)         0.00632
  Cellular component   Axon part                                                                                                                                                                        6 (0)           38 (2)        0.00665
  Biological process   Regulation of mitotic cell cycle                                                                                                                                                 8 (1)           62 (6)        0.00683
  Molecular function   Anion transmembrane transporter activity                                                                                                                                         8 (0)           66 (5)        0.00813
  Biological process   Cell-cell signaling                                                                                                                                                              21 (4)          268 (74)      0.00841
  Molecular function   High-affinity glutamate transmembrane transporter activity                                                                                                                       2 (2)           2 (2)         0.00875
  Cellular component   Cytoplasmic vesicle part                                                                                                                                                         9 (0)           83 (2)        0.00918
  Biological process   Deoxyribonucleoside triphosphate biosynthetic process                                                                                                                            2 (0)           2 (0)         0.00923
  Biological process   Response to calcium ion                                                                                                                                                          5 (4)           28 (25)       0.00969
  Molecular function   Rho guanyl-nucleotide exchange factor activity                                                                                                                                   5 (5)           29 (29)       0.00984
  Biological process   Carboxylic acid transport                                                                                                                                                        9 (0)           81 (1)        0.01005
  Molecular function   Phosphatidylinositol binding                                                                                                                                                     3 (3)           9 (9)         0.01012
  Molecular function   Dicarboxylic acid transmembrane transporter activity                                                                                                                             3 (0)           9 (0)         0.01012
  Biological process   Organic acid transport                                                                                                                                                           9 (0)           82 (0)        0.01077
  Biological process   Glutamate metabolic process                                                                                                                                                      3 (0)           9 (4)         0.01091
  Biological process   Dicarboxylic acid transport                                                                                                                                                      3 (3)           9 (7)         0.01091
  Cellular component   Axoneme                                                                                                                                                                          4 (2)           19 (5)        0.01104
  Molecular function   Structural constituent of cytoskeleton                                                                                                                                           5 (5)           31 (31)       0.01251
  Cellular component   Cytoplasmic membrane-bounded vesicle lumen                                                                                                                                       4 (0)           20 (0)        0.01285
  Cellular component   Platelet alpha granule lumen                                                                                                                                                     4 (4)           20 (20)       0.01285
  Cellular component   Dendritic spine                                                                                                                                                                  4 (4)           20 (20)       0.01285
  Cellular component   Neuron spine                                                                                                                                                                     4 (0)           20 (0)        0.01285
  Cellular component   Axon                                                                                                                                                                             9 (6)           89 (62)       0.01361
  Cellular component   Neurofilament                                                                                                                                                                    2 (2)           3 (3)         0.01394
  Molecular function   Antioxidant activity                                                                                                                                                             5 (2)           32 (12)       0.01401
  Biological process   Rho protein signal transduction                                                                                                                                                  7 (1)           57 (15)       0.01403
  Molecular function   Phenylalanine 4-monooxygenase activity                                                                                                                                           2 (2)           3 (3)         0.0142
  Biological process   ER to Golgi vesicle-mediated transport                                                                                                                                           4 (4)           20 (20)       0.01457
  Cellular component   Vesicle lumen                                                                                                                                                                    4 (0)           21 (1)        0.01484
  Biological process   D-Amino acid transport                                                                                                                                                           2 (0)           3 (0)         0.01497
  Biological process   D-Aspartate import                                                                                                                                                               2 (2)           3 (3)         0.01497
  Biological process   D-Aspartate transport                                                                                                                                                            2 (0)           3 (0)         0.01497
  Biological process   Glutamate biosynthetic process                                                                                                                                                   2 (2)           3 (3)         0.01497
  Biological process   2′-Deoxyribonucleotide biosynthetic process                                                                                                                                      2 (0)           3 (0)         0.01497
  Biological process   Fatty acid transport                                                                                                                                                             4 (1)           21 (6)        0.01681
  Molecular function   Ras guanyl-nucleotide exchange factor activity                                                                                                                                   5 (0)           34 (3)        0.01737
  Biological process   Regulation of cell cycle process                                                                                                                                                 6 (0)           47 (0)        0.01912
  Biological process   Nucleoside triphosphate biosynthetic process                                                                                                                                     8 (1)           76 (3)        0.0195
  Molecular function   Transporter activity                                                                                                                                                             34 (8)          556 (147)     0.01993
  Molecular function   Monocarboxylic acid binding                                                                                                                                                      4 (0)           23 (0)        0.02002
  Cellular component   Neurofilament cytoskeleton                                                                                                                                                       2 (0)           4 (1)         0.02037
  Biological process   Pyrimidine nucleoside triphosphate biosynthetic process                                                                                                                          3 (0)           12 (0)        0.02063
  Biological process   Pyrimidine nucleoside triphosphate metabolic process                                                                                                                             3 (0)           12 (0)        0.02063
  Molecular function   Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen   2 (1)           4 (2)         0.02075
  Molecular function   Thioredoxin-disulfide reductase activity                                                                                                                                         2 (2)           4 (4)         0.02075
  Biological process   Regulation of secretion                                                                                                                                                          8 (0)           77 (0)        0.0208
  Biological process   Neurotransmitter biosynthetic process                                                                                                                                            2 (2)           4 (4)         0.02186
  Biological process   Tetrahydrobiopterin metabolic process                                                                                                                                            2 (1)           4 (1)         0.02186
  Biological process   Deoxyribonucleoside triphosphate metabolic process                                                                                                                               2 (0)           4 (1)         0.02186
  Cellular component   Clathrin coat                                                                                                                                                                    4 (1)           24 (1)        0.02193
  Biological process   Response to metal ion                                                                                                                                                            8 (0)           78 (3)        0.02216
  Cellular component   Transport vesicle membrane                                                                                                                                                       3 (0)           13 (0)        0.02236
  Biological process   Neurotransmitter metabolic process                                                                                                                                               3 (1)           13 (3)        0.02465
  Biological process   Long-chain fatty acid transport                                                                                                                                                  3 (2)           13 (4)        0.02465
  Molecular function   Oxidoreductase activity, acting on sulfur group of donors                                                                                                                        4 (0)           25 (0)        0.02549
  Molecular function   Organic acid:sodium symporter activity                                                                                                                                           3 (0)           14 (0)        0.02707
  Molecular function   Phosphoinositide binding                                                                                                                                                         6 (2)           53 (30)       0.02738
  Molecular function   Carboxylic acid binding                                                                                                                                                          8 (0)           84 (5)        0.02754
  Cellular component   MHC protein complex                                                                                                                                                              4 (0)           26 (0)        0.02764
  Molecular function   DNA topoisomerase type I activity                                                                                                                                                2 (2)           5 (5)         0.02831
  Molecular function   Solute:sodium symporter activity                                                                                                                                                 4 (0)           26 (0)        0.02853
  Cellular component   Synapse                                                                                                                                                                          13 (10)         167 (116)     0.0289
  Biological process   L-Amino acid transport                                                                                                                                                           3 (0)           14 (1)        0.02906
  Biological process   Cilium morphogenesis                                                                                                                                                             3 (1)           14 (3)        0.02906
  Cellular component   Secretory granule                                                                                                                                                                8 (3)           86 (27)       0.02929
  Biological process   Positive regulation of myeloid leukocyte differentiation                                                                                                                         2 (0)           5 (0)         0.0298
  Biological process   Glutamate catabolic process                                                                                                                                                      2 (0)           5 (0)         0.0298
  Biological process   Sulfate transport                                                                                                                                                                2 (2)           5 (5)         0.0298
  Biological process   Deoxyribonucleotide biosynthetic process                                                                                                                                         2 (0)           5 (2)         0.0298
  Cellular component   Endomembrane system                                                                                                                                                              26 (1)          416 (14)      0.03019
  Cellular component   External side of plasma membrane                                                                                                                                                 6 (5)           55 (49)       0.03035
  Cellular component   Plasma membrane                                                                                                                                                                  64 (48)         1224 (935)    0.03044
  Cellular component   Endocytic vesicle membrane                                                                                                                                                       3 (3)           15 (12)       0.03078
  Cellular component   Clathrin coated vesicle membrane                                                                                                                                                 4 (0)           27 (3)        0.0308
  Cellular component   Intrinsic to organelle membrane                                                                                                                                                  8 (0)           87 (0)        0.03095
  Biological process   Regulation of rho protein signal transduction                                                                                                                                    5 (5)           39 (29)       0.03101
  Biological process   Neurotransmitter secretion                                                                                                                                                       4 (3)           26 (11)       0.03114
  Cellular component   Synapse part                                                                                                                                                                     10 (0)          117 (2)       0.03187
  Biological process   Vitamin transport                                                                                                                                                                3 (1)           15 (1)        0.03386
  Molecular function   Symporter activity                                                                                                                                                               6 (6)           57 (44)       0.03631
  Molecular function   Syntaxin-1 binding                                                                                                                                                               2 (2)           6 (6)         0.03678
  Molecular function   Ion channel inhibitor activity                                                                                                                                                   2 (1)           6 (2)         0.03678
  Biological process   Cell communication                                                                                                                                                               34 (4)          562 (40)      0.03717
  Cellular component   Endocytic vesicle                                                                                                                                                                4 (1)           29 (10)       0.03772
  Biological process   Regulation of mitosis                                                                                                                                                            4 (2)           28 (7)        0.03839
  Biological process   Regulation of nuclear division                                                                                                                                                   4 (0)           28 (0)        0.03839
  Biological process   Response to inorganic substance                                                                                                                                                  10 (1)          118 (8)       0.03843
  Biological process   Phosphatidylcholine biosynthetic process                                                                                                                                         2 (2)           6 (5)         0.03869
  Biological process   Interleukin-1 beta secretion                                                                                                                                                     2 (0)           6 (0)         0.03869
  Biological process   Interleukin-1 secretion                                                                                                                                                          2 (0)           6 (0)         0.03869
  Biological process   Regulation of interleukin-1 beta secretion                                                                                                                                       2 (0)           6 (0)         0.03869
  Biological process   Regulation of interleukin-1 secretion                                                                                                                                            2 (0)           6 (0)         0.03869
  Biological process   Cdc42 protein signal transduction                                                                                                                                                2 (1)           6 (3)         0.03869
  Biological process   L-Phenylalanine catabolic process                                                                                                                                                2 (2)           6 (6)         0.03869
  Biological process   L-Phenylalanine metabolic process                                                                                                                                                2 (0)           6 (0)         0.03869
  Biological process   Tyrosine metabolic process                                                                                                                                                       2 (0)           6 (1)         0.03869
  Biological process   Multicellular organismal aging                                                                                                                                                   2 (1)           6 (2)         0.03869
  Biological process   Aspartate transport                                                                                                                                                              2 (0)           6 (3)         0.03869
  Biological process   Negative regulation of transforming growth factor beta receptor signaling pathway                                                                                                2 (2)           6 (6)         0.03869
  Biological process   Neurofilament cytoskeleton organization                                                                                                                                          2 (1)           6 (5)         0.03869
  Molecular function   Chloride ion binding                                                                                                                                                             4 (4)           29 (29)       0.0389
  Biological process   L-Glutamate transport                                                                                                                                                            3 (0)           16 (7)        0.03904
  Biological process   Platelet activation                                                                                                                                                              3 (2)           16 (11)       0.03904
  Biological process   Positive regulation of secretion                                                                                                                                                 5 (0)           42 (1)        0.03976
  Molecular function   Substrate-specific transporter activity                                                                                                                                          28 (0)          463 (0)       0.04034
  Biological process   Nucleotide biosynthetic process                                                                                                                                                  12 (0)          151 (7)       0.04052
  Cellular component   Microtubule basal body                                                                                                                                                           3 (3)           17 (17)       0.04062
  Molecular function   Calcium-dependent protein binding                                                                                                                                                3 (3)           17 (17)       0.04164
  Biological process   Anion transport                                                                                                                                                                  7 (0)           73 (10)       0.04185
  Molecular function   Solute:cation symporter activity                                                                                                                                                 5 (0)           44 (0)        0.04201
  Biological process   Purine nucleoside triphosphate biosynthetic process                                                                                                                              7 (0)           74 (0)        0.0443
  Biological process   Acidic amino acid transport                                                                                                                                                      3 (0)           17 (0)        0.04461
  Biological process   Pyrimidine nucleoside metabolic process                                                                                                                                          3 (0)           17 (1)        0.04461
  Biological process   Pyrimidine nucleotide biosynthetic process                                                                                                                                       3 (0)           17 (4)        0.04461
  Cellular component   MHC class II protein complex                                                                                                                                                     3 (3)           18 (18)       0.04607
  Molecular function   Oxidoreductase activity, acting on sulfur group of donors, NAD, or NADP as acceptor                                                                                              2 (0)           7 (2)         0.04608
  Molecular function   Fatty acid transporter activity                                                                                                                                                  2 (1)           7 (3)         0.04608
  Molecular function   Channel inhibitor activity                                                                                                                                                       2 (0)           7 (1)         0.04608
  Molecular function   DNA topoisomerase activity                                                                                                                                                       2 (1)           7 (2)         0.04608
  Biological process   Regulation of cytokine production                                                                                                                                                7 (0)           75 (0)        0.04684
  Molecular function   NADP or NADPH binding                                                                                                                                                            3 (3)           18 (17)       0.04721
  Biological process   Nucleobase, nucleoside, and Nucleotide biosynthetic process                                                                                                                      12 (0)          157 (0)       0.04725
  Biological process   Nucleobase, nucleoside, nucleotide, and nucleic acid biosynthetic process                                                                                                        12 (0)          157 (0)       0.04725
  Biological process   G1 phase                                                                                                                                                                         2 (1)           7 (1)         0.04845
  Cellular component   Lamellipodium                                                                                                                                                                    4 (4)           32 (32)       0.04965
  Cellular component   Transport vesicle                                                                                                                                                                4 (1)           32 (11)       0.04965

###### 

Gene ontology of downregulated genes in Y-27632-treated TM cells.

  Ontology             Term                                                                                                           Changed genes   Total genes   *P* value
  -------------------- -------------------------------------------------------------------------------------------------------------- --------------- ------------- -----------
  Molecular function   Endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5′-phosphomonoesters   2 (0)           13 (0)        0.00279
  Biological process   Antigen processing and presentation of peptide or polysaccharide antigen via MHC class II                      2 (2)           16 (14)       0.00421
  Cellular component   MHC class II protein complex                                                                                   2 (2)           18 (18)       0.00606
  Molecular function   D-Dopachrome decarboxylase activity                                                                            1 (1)           1 (1)         0.01065
  Molecular function   Glucose 1-dehydrogenase activity                                                                               1 (1)           1 (1)         0.01065
  Molecular function   Glucose-6-phosphate dehydrogenase activity                                                                     1 (1)           1 (1)         0.01065
  Molecular function   Deoxyribonuclease I activity                                                                                   1 (1)           1 (1)         0.01065
  Molecular function   3′-Phosphoadenosine 5′-phosphosulfate transmembrane transporter activity                                       1 (1)           1 (1)         0.01065
  Biological process   Olfactory behavior                                                                                             1 (1)           1 (1)         0.01091
  Biological process   Positive regulation of dopamine receptor signaling pathway                                                     1 (1)           1 (1)         0.01091
  Biological process   Regulation of dopamine receptor signaling pathway                                                              1 (0)           1 (0)         0.01091
  Biological process   3′-Phosphoadenosine 5′-phosphosulfate transport                                                                1 (1)           1 (1)         0.01091
  Biological process   Negative regulation of neuron apoptosis                                                                        2 (2)           28 (28)       0.01148
  Cellular component   MHC protein complex                                                                                            2(0)            26(0)         0.01171
  Molecular function   Toxin binding                                                                                                  1 (1)           2 (2)         0.01594
  Molecular function   C2H2 zinc finger domain binding                                                                                1 (1)           2 (2)         0.01594
  Molecular function   Dopachrome isomerase activity                                                                                  1 (1)           2 (2)         0.01594
  Molecular function   6-Phosphogluconolactonase activity                                                                             1 (1)           2 (2)         0.01594
  Molecular function   Hedgehog receptor activity                                                                                     1 (1)           2 (2)         0.01594
  Molecular function   Dihydrofolate reductase activity                                                                               1 (1)           2 (2)         0.01594
  Molecular function   Purine nucleoside transmembrane transporter activity                                                           1 (0)           2 (1)         0.01594
  Biological process   Cytolysis by symbiont of host cells                                                                            1 (0)           2 (0)         0.01632
  Biological process   Cytolysis of cells in other organism during symbiotic interaction                                              1 (0)           2 (0)         0.01632
  Biological process   Cytolysis of cells of another organism                                                                         1 (0)           2 (0)         0.01632
  Biological process   Disruption by symbiont of host cells                                                                           1 (0)           2 (0)         0.01632
  Biological process   Hemolysis by symbiont of host erythrocytes                                                                     1 (1)           2 (2)         0.01632
  Biological process   Hemolysis of cells in other organism                                                                           1 (0)           2 (0)         0.01632
  Biological process   Hemolysis of cells in other organism during symbiotic interaction                                              1 (0)           2 (0)         0.01632
  Biological process   Killing by symbiont of host cells                                                                              1 (0)           2 (0)         0.01632
  Biological process   Maintenance of mitochondrion location                                                                          1 (1)           2 (2)         0.01632
  Biological process   Modification by organism of cell membrane in other organism during symbiotic interaction                       1 (0)           2 (0)         0.01632
  Biological process   Modification by symbiont of host cell membrane                                                                 1 (0)           2 (0)         0.01632
  Biological process   Modification by symbiont of host cellular component                                                            1 (0)           2 (0)         0.01632
  Biological process   Modification by symbiont of host structure                                                                     1 (0)           2 (0)         0.01632
  Biological process   Modification of cellular component in other organism during symbiotic interaction                              1 (0)           2 (0)         0.01632
  Biological process   Modification of structure of other organism during symbiotic interaction                                       1 (0)           2 (0)         0.01632
  Biological process   Caveola assembly                                                                                               1 (1)           2 (2)         0.01632
  Biological process   Membrane raft assembly                                                                                         1 (0)           2 (0)         0.01632
  Biological process   Positive regulation of G-protein coupled receptor protein signaling pathway                                    1 (0)           2 (1)         0.01632
  Biological process   Chromatin-mediated maintenance of transcription                                                                1 (1)           2 (2)         0.01632
  Biological process   Positive regulation of gene expression, epigenetic                                                             1 (0)           2 (0)         0.01632
  Biological process   ncRNA catabolic process                                                                                        1 (0)           2 (0)         0.01632
  Biological process   rRNA catabolic process                                                                                         1 (1)           2 (2)         0.01632
  Biological process   Purine nucleoside transport                                                                                    1 (0)           2 (1)         0.01632
  Biological process   Striated muscle cell differentiation                                                                           2 (1)           38 (5)        0.0199
  Biological process   Antigen processing and presentation                                                                            2 (2)           38 (32)       0.0199
  Molecular function   Copper ion binding                                                                                             2 (2)           39 (38)       0.01996
  Molecular function   Endodeoxyribonuclease activity, producing 5′-phosphomonoesters                                                 1 (0)           3 (1)         0.0212
  Cellular component   Membrane                                                                                                       24 (17)         2769 (1768)   0.02168
  Biological process   Maintenance of organelle location                                                                              1 (0)           3 (0)         0.02171
  Biological process   Melanin biosynthetic process                                                                                   1 (1)           3 (3)         0.02171
  Biological process   Melanin metabolic process                                                                                      1 (0)           3 (0)         0.02171
  Biological process   Endoplasmic reticulum calcium ion homeostasis                                                                  1 (1)           3 (1)         0.02171
  Biological process   Multicellular organismal water homeostasis                                                                     1 (0)           3 (0)         0.02171
  Biological process   Renal water homeostasis                                                                                        1 (1)           3 (1)         0.02171
  Biological process   Positive regulation of Rac protein signal transduction                                                         1 (1)           3 (3)         0.02171
  Biological process   Apoptosis                                                                                                      7 (3)           522 (189)     0.0221
  Biological process   Programmed cell death                                                                                          7 (0)           525 (2)       0.02273
  Cellular component   Extrinsic to internal side of plasma membrane                                                                  1 (1)           3 (3)         0.02347
  Cellular component   Spectrin                                                                                                       1 (1)           3 (3)         0.02347
  Molecular function   Endonuclease activity                                                                                          2 (2)           43 (30)       0.02378
  Molecular function   Nucleoside transmembrane transporter activity                                                                  1 (0)           4 (1)         0.02643
  Biological process   Regulation of neuron apoptosis                                                                                 2 (0)           45 (2)        0.02693
  Biological process   Detection of visible light                                                                                     1 (1)           4 (1)         0.02706
  Biological process   Chemosensory behavior                                                                                          1 (0)           4 (3)         0.02706
  Biological process   Protein maturation by protein folding                                                                          1 (1)           4 (4)         0.02706
  Biological process   Cellular chaperone-mediated protein complex assembly                                                           1 (1)           4 (2)         0.02706
  Biological process   Mitochondrial outer membrane translocase complex assembly                                                      1 (1)           4 (4)         0.02706
  Biological process   Outer mitochondrial membrane organization                                                                      1 (0)           4 (0)         0.02706
  Biological process   Glycine biosynthetic process                                                                                   1 (1)           4 (2)         0.02706
  Cellular component   Membrane part                                                                                                  21 (0)          2325 (1)      0.02771
  Biological process   Cellular membrane organization                                                                                 4 (0)           212 (30)      0.02909
  Biological process   Membrane organization                                                                                          4 (0)           212 (0)       0.02909
  Biological process   Neuron apoptosis                                                                                               2 (0)           48 (3)        0.03021
  Biological process   Neuron death                                                                                                   2 (0)           48 (0)        0.03021
  Biological process   Muscle cell differentiation                                                                                    2 (0)           49 (1)        0.03134
  Biological process   Disruption of cells of other organism during symbiotic interaction                                             1 (0)           5 (0)         0.03239
  Biological process   Killing of cells in other organism during symbiotic interaction                                                1 (0)           5 (0)         0.03239
  Biological process   Water homeostasis                                                                                              1 (0)           5 (1)         0.03239
  Biological process   Endoplasmic reticulum organization                                                                             1 (1)           5 (5)         0.03239
  Biological process   Membrane raft organization                                                                                     1 (0)           5 (1)         0.03239
  Biological process   Pinocytosis                                                                                                    1 (1)           5 (2)         0.03239
  Biological process   Nucleoside transport                                                                                           1 (0)           5 (2)         0.03239
  Biological process   Response to light stimulus                                                                                     2 (0)           51 (8)        0.03364
  Biological process   Cell death                                                                                                     7 (0)           578 (68)      0.03597
  Biological process   Vesicle-mediated transport                                                                                     5 (2)           336 (120)     0.03622
  Biological process   Death                                                                                                          7 (0)           579 (0)       0.03626
  Biological process   Positive regulation of signaling pathway                                                                       3 (0)           133 (0)       0.03743
  Biological process   Modification by host of symbiont morphology or physiology                                                      1 (0)           6 (0)         0.03769
  Biological process   ER overload response                                                                                           1 (1)           6 (5)         0.03769
  Biological process   Regulation of Rac protein signal transduction                                                                  1 (0)           6 (1)         0.03769
  Molecular function   Actin binding                                                                                                  3 (3)           139 (121)     0.0394
  Cellular component   HOPS complex                                                                                                   1 (1)           6 (6)         0.04072
  Molecular function   Intramolecular oxidoreductase activity, transposing C=C bonds                                                  1 (0)           7 (0)         0.04196
  Biological process   Detection of light stimulus                                                                                    1 (0)           7 (0)         0.04296
  Biological process   Metabotropic glutamate receptor signaling pathway                                                              1 (1)           7 (4)         0.04296
  Biological process   Regulation of synaptic transmission, GABAergic                                                                 1 (1)           7 (2)         0.04296
  Cellular component   Internal side of plasma membrane                                                                               1 (0)           7 (4)         0.04641
  Molecular function   Scavenger receptor activity                                                                                    1 (1)           8 (8)         0.04708
  Biological process   Interaction with symbiont                                                                                      1 (0)           8 (1)         0.0482
  Biological process   Modification by symbiont of host morphology or physiology                                                      1 (0)           8 (0)         0.0482
  Biological process   Chaperone-mediated protein complex assembly                                                                    1 (0)           8 (4)         0.0482
  Biological process   Positive regulation of Ras protein signal transduction                                                         1 (0)           8 (4)         0.0482
  Biological process   Positive regulation of small GTPase-mediated signal transduction                                               1 (0)           8 (0)         0.0482
  Biological process   Synaptic transmission, GABAergic                                                                               1 (0)           8 (1)         0.0482
  Biological process   Actin filament capping                                                                                         1 (1)           8 (6)         0.0482
  Biological process   Pentose-phosphate shunt                                                                                        1 (1)           8 (7)         0.0482
  Biological process   Calcium ion transport                                                                                          2 (1)           63 (41)       0.04876
  Cellular component   Intrinsic to membrane                                                                                          17 (0)          1867 (20)     0.0491

[^1]: Academic Editor: Ciro Costagliola
